US20150073515A1 - Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods - Google Patents
Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods Download PDFInfo
- Publication number
- US20150073515A1 US20150073515A1 US14/021,838 US201314021838A US2015073515A1 US 20150073515 A1 US20150073515 A1 US 20150073515A1 US 201314021838 A US201314021838 A US 201314021838A US 2015073515 A1 US2015073515 A1 US 2015073515A1
- Authority
- US
- United States
- Prior art keywords
- wire
- shaft
- assembly
- catheter
- thermocouple
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/28—Apparatus for applying thermoelectric currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00434—Neural system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00505—Urinary tract
- A61B2018/00511—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00821—Temperature measured by a thermocouple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/144—Wire
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
Definitions
- the present technology relates generally to neuromodulation and associated systems and methods.
- several embodiments are directed to catheters having energy delivering thermocouple assemblies for intravascular neuromodulation and associated systems and methods.
- the sympathetic nervous system is a primarily involuntary bodily control system typically associated with stress responses. Fibers of the SNS innervate tissue in almost every organ system of the human body and can affect characteristics such as pupil diameter, gut motility, and urinary output. Such regulation can have adaptive utility in maintaining homeostasis or preparing the body for rapid response to environmental factors. Chronic activation of the SNS, however, is a common maladaptive response that can drive the progression of many disease states. Excessive activation of the renal SNS in particular has been identified experimentally and in humans as a likely contributor to the complex pathophysiology of hypertension, states of volume overload (such as heart failure), and progressive renal disease. For example, radiotracer dilution has demonstrated increased renal norepinephrine (“NE”) spillover rates in patients with essential hypertension.
- NE renal norepinephrine
- Cardio-renal sympathetic nerve hyperactivity can be particularly pronounced in patients with heart failure. For example, an exaggerated NE overflow from the heart and kidneys to plasma is often found in these patients. Heightened SNS activation commonly characterizes both chronic and end stage renal disease. In patients with end stage renal disease, NE plasma levels above the median have been demonstrated to be predictive of cardiovascular diseases and several causes of death. This is also true for patients suffering from diabetic or contrast nephropathy. Evidence suggests that sensory afferent signals originating from diseased kidneys are major contributors to initiating and sustaining elevated central sympathetic outflow.
- Sympathetic nerves innervating the kidneys terminate in the blood vessels, the juxtaglomerular apparatus, and the renal tubules. Stimulation of the renal sympathetic nerves can cause increased renin release, increased sodium (Na+) reabsorption, and a reduction of renal blood flow. These neural regulation components of renal function are considerably stimulated in disease states characterized by heightened sympathetic tone and likely contribute to increased blood pressure in hypertensive patients. The reduction of renal blood flow and glomerular filtration rate as a result of renal sympathetic efferent stimulation is likely a cornerstone of the loss of renal function in cardio-renal syndrome (i.e., renal dysfunction as a progressive complication of chronic heart failure).
- Pharmacologic strategies to thwart the consequences of renal efferent sympathetic stimulation include centrally acting sympatholytic drugs, beta blockers (intended to reduce renin release), angiotensin converting enzyme inhibitors and receptor blockers (intended to block the action of angiotensin II and aldosterone activation consequent to renin release), and diuretics (intended to counter the renal sympathetic mediated sodium and water retention).
- These pharmacologic strategies have significant limitations including limited efficacy, compliance issues, side effects, and others.
- intravascular devices that reduce sympathetic nerve activity by applying an energy field to a target site in the renal blood vessel e.g., via radiofrequency ablation
- FIG. 1A is an enlarged cross-sectional side view illustrating a therapeutic assembly of a neuromodulation catheter apparatus following a step in a process for assembling the therapeutic assembly from an unassembled state outside a patient in accordance with an embodiment of the present technology.
- FIG. 1B is a side view of the therapeutic assembly of the catheter apparatus shown in FIG. 1A , following another step in the assembly process of the therapeutic assembly, with the therapeutic assembly shown in a delivery state (e.g., low-profile or collapsed configuration) in accordance with an embodiment of the present technology.
- a delivery state e.g., low-profile or collapsed configuration
- FIG. 1C is a perspective view of the distal portion of the catheter apparatus of FIG. 1B in a deployed state (e.g., expanded configuration) in accordance with an embodiment of the present technology.
- a deployed state e.g., expanded configuration
- FIG. 1D is a partially schematic side view of the distal portion of the catheter apparatus of FIG. 1C in the deployed state.
- FIG. 2A is an enlarged cross-sectional side view illustrating a therapeutic assembly of a neuromodulation catheter apparatus following a step in a process for assembling the therapeutic assembly from an unassembled state outside a patient in accordance with another embodiment of the present technology.
- FIGS. 2B and 2C are enlarged, partial cross-sectional side views illustrating assembly stages following additional steps in the process for making the therapeutic assembly of the catheter apparatus shown in FIG. 2A in accordance with embodiments of the present technology.
- FIG. 2D is a perspective view of the distal portion of the catheter apparatus of FIG. 2C in a deployed state (e.g., expanded configuration) in accordance with an embodiment of the present technology.
- a deployed state e.g., expanded configuration
- FIG. 3 is a perspective view of a distal portion of a catheter having a therapeutic assembly or treatment section in a deployed state (e.g., expanded configuration) in accordance with a further embodiment of the present technology.
- FIG. 4 is a partially schematic diagram of a neuromodulation system configured in accordance with an embodiment of the present technology.
- FIG. 5 illustrates modulating renal nerves with a catheter apparatus configured in accordance with an embodiment of the present technology.
- the present technology is directed to apparatuses, systems, and methods for achieving thermally-induced neuromodulation (i.e., rendering neural fibers that innervate, for example, the kidney or another physiological organ or structure inert or inactive or otherwise completely or partially reduced in function) by percutaneous transluminal intravascular access.
- embodiments of the present technology relate to catheters and catheter assemblies having energy delivering thermocouple assemblies and being movable between a delivery or low-profile state (e.g., a generally straight shape) and a deployed state (e.g., a radially expanded shape, generally spiral/helical shape, an expanded lasso shape, J-shape, etc.).
- the thermocouple assembly may include a plurality of non-insulated energy-delivery portions of a first thermocouple wire (e.g., a silver-coated nickel wire, a silver wire, a nickel wire, a copper wire with biocompatible coating thereon, etc.) that can be coupled to or otherwise extend along or about a longitudinal dimension of a catheter shaft, and may include a second insulated thermocouple wire (e.g., a constantan wire) for thermocouple functionality.
- a first thermocouple wire e.g., a silver-coated nickel wire, a silver wire, a nickel wire, a copper wire with biocompatible coating thereon, etc.
- a second insulated thermocouple wire e.g., a constantan wire
- thermocouple assembly is in electrical communication with an energy source or energy generator such that energy is delivered from the non-insulated energy delivery portions of the first thermocouple wire to portions of an artery after being advanced thereto via a catheter along a percutaneous transluminal path (e.g., a femoral artery puncture, an iliac artery and the aorta, a radial artery, or another suitable intravascular path).
- a percutaneous transluminal path e.g., a femoral artery puncture, an iliac artery and the aorta, a radial artery, or another suitable intravascular path.
- Any suitable energy modality may be used (e.g., electrical energy such as radiofrequency (RF) energy, pulsed energy, etc.).
- the catheter or catheter assembly carrying the thermocouple assembly may be sized and shaped so that the non-insulated energy delivery portions contact an interior wall of an artery (e.g., a renal artery, an ovarian artery, testicular artery, external iliac artery, internal iliac artery, internal pudendal artery, uterine artery, celiac artery, superior mesenteric artery, hepatic artery, splenic artery, gastric artery, pancreatic artery, and/or associated arterial branches, etc.) when the catheter is in the deployed state within the artery.
- an artery e.g., a renal artery, an ovarian artery, testicular artery, external iliac artery, internal iliac artery, internal pudendal artery, uterine artery, celiac artery, superior mesenteric artery, hepatic artery, splenic artery, gastric artery, pancreatic artery, and/or associated arterial
- the pre-formed expanded shape (e.g., spiral/helical, lasso, J-shape, etc.) of the deployed portion of the catheter carrying the thermocouple assembly allows blood to flow through the helix, which is expected to help avoid occlusion of the artery during activation of the non-insulated energy delivery portions of the thermocouple wire.
- thermocouple assembly for inducing neuromodulation that include separate electrodes or arrays of electrodes can be expensive to manufacture. These designs may require separate wiring of each electrode to a conventional thermocouple wire, as well as complex algorithms and energy generator designs to operate.
- thermocouple assembly presented herein includes a single energy delivering wire (e.g., the first wire) that can have direct electrical communication with an energy generator, and each non-insulated energy delivery portion of the single wire is in electrical communication with each of the other non-insulated energy delivery portions along the wire. This is expected to reduce manufacturing time and material costs associated with separate electrodes and wiring, as well as reduce the complexity of the control algorithm typically necessary to operate more than one independent electrode or energy delivery element.
- FIGS. 1A-5 Specific details of several embodiments of the technology are described below with reference to FIGS. 1A-5 . Although many of the embodiments are described below with respect to devices, systems, and methods for intravascular modulation of sympathetic nerves using thermocouple assemblies, other applications and other embodiments in addition to those described herein are within the scope of the technology. Additionally, several other embodiments of the technology can have different configurations, components, or procedures than those described herein. A person of ordinary skill in the art, therefore, will accordingly understand that the technology can have other embodiments with additional elements, or the technology can have other embodiments without several of the features shown and described below with reference to FIGS. 1A-5 .
- distal and proximal define a position or direction with respect to the treating clinician or clinician's control device (e.g., a handle assembly). “Distal” or “distally” are a position distant from or in a direction away from the clinician or clinician's control device. “Proximal” and “proximally” are a position near or in a direction toward the clinician or clinician's control device.
- FIGS. 1A and 1B illustrate assembly stages following steps in a method of forming a catheter apparatus 100 (“catheter 100 ”) having a therapeutic assembly 110 in a distal portion 102 of the catheter 100 for therapeutically modulating sympathetic nerves in a patient in accordance with an embodiment of the present technology.
- FIG. 1C is a perspective view of the distal portion 102 of the catheter 100 of FIG. 1B in a deployed state 103 (e.g., expanded configuration).
- the distal portion 102 includes an elongated tubular shaft 120
- the therapeutic assembly 110 can include the shaft 120 and a thermocouple assembly 130 positioned along the shaft 120 .
- the therapeutic assembly 110 can be transformed or actuated between a delivery state 101 (e.g., a low-profile or collapsed configuration, FIG. 1B ) and the deployed state 103 (e.g., a radially expanded, generally spiral configuration, FIG. 1C ) in which the therapeutic assembly 110 is configured to contact a wall of a blood vessel (e.g., a renal blood vessel).
- a delivery state 101 e.g., a low-profile or collapsed configuration, FIG. 1B
- the deployed state 103 e.g., a radially expanded, generally spiral configuration, FIG. 1C
- a blood vessel e.g., a renal blood vessel
- the therapeutic assembly 110 of the catheter 100 is shown in various stages of assembly for forming the catheter apparatus 100 in a delivery state 101 (e.g., low-profile or collapsed configuration) outside of a patient.
- the shaft 120 can include a flexible tube 122 and a pre-shaped spiral/helical control member 124 within the tube 122 .
- the flexible tube 122 may be composed of a polymer material such as: polyamide; polyimide; polyether block amide copolymer sold under the trademark PEBAX; polyethylene terephthalate (PET); polypropylene; aliphatic, polycarbonate-based thermoplastic polyurethane sold under the trademark CARBOTHANE; or a polyether ether ketone (PEEK) polymer that provides the desired flexibility.
- a polymer material such as: polyamide; polyimide; polyether block amide copolymer sold under the trademark PEBAX; polyethylene terephthalate (PET); polypropylene; aliphatic, polycarbonate-based thermoplastic polyurethane sold under the trademark CARBOTHANE; or a polyether ether ketone (PEEK) polymer that provides the desired flexibility.
- the tube 122 may be composed of other suitable materials.
- the pre-shaped control member 124 may be used to provide a spiral/helical shape to the shaft 120 in the distal portion 102 of the catheter 100 .
- the control member 124 can be a tubular structure comprising a nitinol multifilar stranded wire with a lumen therethrough and sold under the trademark HELICAL HOLLOW STRAND (HHS), and commercially available from Fort Wayne Metals of Fort Wayne, Ind.
- HHS HELICAL HOLLOW STRAND
- the tubular control member 124 may be formed from a variety of different types of materials, may be arranged in a single or dual-layer configuration, and may be manufactured with a selected tension, compression, torque and pitch direction.
- the HHS material for example, may be cut using a laser, electrical discharge machining (EDM), electrochemical grinding (ECG), or other suitable means to achieve a desired finished component length and geometry.
- control member 124 of Nitinol multifilar stranded wire(s) or other similar materials is expected to provide a desired level of support and rigidity to the therapeutic assembly 110 without additional reinforcement wire(s) or other reinforcement features within the shaft 120 . This feature is expected to reduce the number of manufacturing processes required to form the catheter 100 and reduce the number of materials required for the device.
- the control member 124 and inner wall of the tube 122 can be in intimate contact with little or no space between the control member 124 and the tube 122 .
- the tube 122 can have a larger diameter than the control member 124 prior to assembly such that applying hot air to the tube 122 during the manufacturing process shrinks the tube onto the control member 124 , as will be understood by those familiar with the ordinary use of shrink tubing materials.
- This feature is expected to inhibit or eliminate wrinkles or kinks that might occur in the tube 122 as the therapeutic assembly 110 transforms from the relatively straight delivery state 101 to the deployed, generally spiral state 103 ( FIG. 1C ).
- control member 124 and/or other components of the shaft 120 may be composed of different materials and/or have a different arrangement.
- the control member 124 may be formed from other suitable shape memory materials (e.g., nickel-titanium (Nitinol), wire or tubing besides HHS, shape memory polymers, electro-active polymers) that are pre-formed or pre-shaped into the desired deployed state.
- the control member 124 may be formed from multiple materials such as a composite of one or more polymers and metals.
- FIG. 1A illustrates a stage in the method of forming the therapeutic assembly 110 in the distal portion 102 of the catheter 100 after the thermocouple assembly 130 has been aligned with and positioned alongside the shaft 120 .
- the thermocouple assembly 130 includes a conductive first wire 131 and a second wire 132 joined at a junction 133 at least proximate to the shaft 120 .
- the first and second wires 131 , 132 can be dissimilar metals.
- the first and second wires 131 , 132 can be at least partially covered by an insulative cover 137 , such as compacted mineral insulation and an outer sheath, or other appropriate conductive wire insulation known in the art.
- the conductive first wire 131 can include an insulated energy delivery or transmitting wire that can relay and/or transmit an energy signal from an energy source (not shown), such as an RF energy generator located outside of the patient.
- RF signals can be transmitted along a length of the conductive first wire 131 to the therapeutic assembly 110 .
- FIG. 1A also shows a stage in the method after selected portions of the insulating cover 137 have been removed from along the conductive first wire 131 to form a plurality of exposed regions 134 (e.g., uninsulated regions) separated from each other by insulated regions 135 along a portion of the first wire 131 proximate the shaft 120 (e.g., in the distal portion 102 of the catheter 100 ).
- the exposed regions 134 of the conductive first wire 131 can define a plurality of energy delivery portions 136 a - 136 d (referred to collectively as energy delivery portions 136 ) configured to deliver electrical energy (e.g., RF energy, pulsed energy, etc.) to target tissue.
- electrical energy e.g., RF energy, pulsed energy, etc.
- the energy delivery portions 136 are along the same conductive path and, accordingly, commonly connected to an energy source.
- the thermocouple assembly 130 can include more than one exposed region 134 along the first wire 131 .
- the thermocouple assembly 130 can include between 2 and about 8 exposed regions 134 along the first wire 131 , or between 2 and about 6 exposed regions 134 , or between 2 and about 4 exposed regions 134 , or about 4 exposed regions 134 .
- the energy delivery portions 136 a - 136 d may be equally spaced apart along a length L 1 of the therapeutic assembly 110 .
- first energy delivery portion 136 a may have a first size (e.g., a first length) and a second energy delivery portion 136 b may have a second size (e.g., a second length) different than the first size, and/or first and second energy delivery portions 136 a and 136 b may be spaced apart by a different distance than second and third energy delivery portions 136 b and 136 c.
- first size e.g., a first length
- second energy delivery portion 136 b may have a second size (e.g., a second length) different than the first size
- first and second energy delivery portions 136 a and 136 b may be spaced apart by a different distance than second and third energy delivery portions 136 b and 136 c.
- the thermocouple assembly 130 can also include the second wire 132 , which can be a wire that is at least insulated along the shaft 120 .
- the second wire 132 can run parallel to the first wire 131 and can be electrically coupled to the junction 133 .
- the first wire 131 and the second wire 132 include dissimilar metals such that the electric potential between the two wires 131 , 132 formed at the junction 133 relates to a temperature reading at the junction (e.g., at the therapeutic assembly 110 ).
- the first wire 131 comprises a conductive material, such as nickel, silver, or in another embodiment, silver-coated nickel.
- the conductive first wire 131 and/or the exposed regions 134 of the first wire 131 can be coated with a biocompatible conductive material (not shown), such as gold or platinum.
- a biocompatible conductive material such as gold or platinum.
- a non-biocompatible material e.g., copper
- a biocompatible conductive material such as gold or platinum (e.g., coating for the non-biocompatible materials).
- Biocompatible materials and/or coatings can be used with any of the thermocouple assemblies 130 described herein. Additional intermediate bonding materials (e.g., tantalum, titanium, etc.) may also be included.
- the second wire 132 can be an insulated constantan wire.
- thermocouple assembly 130 can be a Type T thermocouple and the first wire 131 can be copper (e.g., gold or platinum coated copper) and the second wire 132 can be constantan.
- the thermocouple assembly 130 can measure temperatures in the temperature range of about ⁇ 200° C. to about 350° C.
- FIG. 1B illustrates a stage in the method after the thermocouple assembly 130 has been helically/spirally positioned about the shaft 120 (e.g., in the distal portion 102 of the catheter 100 ).
- the shaft 120 supports the thermocouple assembly 130 about an outer circumference of the distal portion of the catheter 100 and along a length L 1 of the therapeutic assembly 110 .
- the thermocouple assembly 130 can be helically positioned (e.g., wound, wrapped, arranged, etc.) about the shaft 120 (e.g., in the distal portion 102 of the catheter 100 ) while the therapeutic assembly 110 is in the delivery state 101 .
- thermocouple assembly 130 can be positioned about the shaft 120 to create a helical shape; however, a variety of helical or non-helical arrangements are suitable for positioning the thermocouple assembly 130 on or about the shaft 120 .
- the thermocouple assembly 130 may have a pitch of about 1 mm to 12 mm. In other embodiments, however, the thermocouple assembly 130 may have different dimensions.
- the thermocouple assembly 130 may be coupled or attached to the shaft 120 (e.g., attached to the flexible tube 122 ) at one or more locations along the shaft 120 using adhesives (e.g., thermal bonds), fasteners, and/or other suitable attachment mechanisms known in the art (e.g., clips, ties, staples, collars, etc.).
- the therapeutic assembly 110 can include proximal and distal connectors or retainers (not shown), such as collars or other suitable fasteners to which proximal and distal portions of the thermocouple assembly 130 , respectively, may be attached.
- the first and second wires 131 , 132 can be helically positioned around the shaft 120 between the proximal and distal connectors (not shown).
- such connectors may be attached over select portions of the shaft 120 , thereby coupling the thermocouple assembly 130 to the shaft 120 .
- the connectors can be attached to the shaft 120 , for example, using thermal bonds, adhesives, interlocking surfaces (e.g., threads), friction fit, snap fit, suction, and/or other suitable attachment mechanisms, or the connectors can be formed integrally with the thermocouple assembly 130 and/or the shaft 120 .
- the therapeutic assembly 110 does not include additional connectors or attachment means, but can be retained against the shaft 120 with a guide sheath or loading tool (not shown) that is moved over the length L 1 of the therapeutic assembly 110 during advancement and retrieval.
- the junction 133 of the thermocouple assembly 130 can be positioned at a distal end of the therapeutic assembly 110 which may or may not be a distal end 126 of the shaft 120 ( FIGS. 1B and 1C ).
- the catheter 100 terminates at an atraumatic tip 128 at the distal end 126 of the shaft 120 ( FIG. 1B ).
- the atraumatic tip 128 can be a flexible curved tip.
- the atraumatic tip 128 may have a distal opening (not shown) for accommodating a guide wire (not shown) that directs the guide wire away from the wall of the artery when the therapeutic assembly 110 is in the pre-set deployed state 103 ( FIG. 1C ).
- the curvature of the tip 128 can be varied depending upon the particular sizing/configuration of the therapeutic assembly 110 .
- the tip 128 may also comprise one or more radiopaque markers (not shown) and/or one or more sensors (not shown).
- the tip 128 can be part of (e.g., an extension of or integral with) the shaft 120 .
- the flexible tip 128 can be a more flexible tapered portion (e.g., about 5 to about 7 mm) of the distal end 126 of the shaft 120 . Such an arrangement can be suitable for guidewire delivery of the therapeutic assembly 110 to the target treatment site.
- the tip 128 can be a separate component that may be affixed to the distal end 126 of the shaft 120 via adhesive, crimping, over-molding, or other suitable techniques.
- the tip 128 can be made from a polymer material (e.g., a polyether block amide copolymer sold under the trademark PEBAX, or a thermoplastic polyether urethane material sold under the trademarks ELASTHANE or PELLETHANE), or other suitable materials having the desired properties, including a selected durometer.
- the tip 128 may be formed from different material(s) and/or have a different arrangement.
- FIG. 1C is a perspective view of the distal portion 102 of the catheter 100 of FIG. 1B in the deployed state 103 (e.g., expanded configuration) in accordance with an embodiment of the present technology.
- the control member 124 FIG. 1A
- the control member 124 has a pre-set spiral/helical configuration that defines the deployed state 103 of the therapeutic assembly 110 such that the energy delivery portions 136 a - 136 d of the thermocouple assembly 130 are offset from each other (e.g., both angularly and circumferentially offset relative to a longitudinal axis of the artery and/or angularly offset from each other along an axis of the shaft 120 when the thermocouple assembly 130 is in the deployed configuration).
- This configuration can provide stable apposition of the energy delivery portions 136 a - 136 d with an inner surface of a wall of the artery (not shown) for treatment.
- the exposed regions 134 along the first wire 131 of the thermocouple assembly 130 are spaced apart from each other. However, because the insulated regions 134 expose portions of a single first wire 131 , the energy delivery portions 136 a - 136 d defined by the exposed regions 134 are in electrical communication with each other (e.g., commonly connected to an energy source).
- the therapeutic assembly 110 can deliver neuromodulating energy from a power source (not shown) and through the thermocouple assembly 130 (e.g., through the first wire 131 ) to the energy delivery portions 136 a - 136 d .
- energy e.g., electrical energy such as RF energy and pulsed energy
- tissue at the treatment location within the artery e.g., renal artery
- an RF energy field can be delivered to the target nerves adjacent the wall of the artery via the energy delivery portions 136 a - 136 d .
- the energy delivery portions 136 a - 136 are spaced apart both circumferentially and longitudinally along the wall of the interior lumen of the artery when the therapeutic assembly 110 is in the deployed state 103 . Accordingly, application of energy via the energy delivery portions 136 a - 136 d can result in a plurality of discontinuous lesions along the wall of the interior lumen of the artery. Temperature of the target tissue proximate the therapeutic assembly 110 can be measured and monitored by the thermocouple assembly 130 at the junction 133 .
- the catheter 100 may be configured for guidewire based delivery (e.g., over-the-wire (“OTW”) delivery, rapid exchange (“RX”) delivery) from an access site in which a guide wire (not shown) is initially inserted to a treatment site (e.g., within a renal artery), and the catheter 100 is advanced over the guide wire.
- a guide wire e.g., over-the-wire (“OTW”) delivery, rapid exchange (“RX”) delivery
- RX rapid exchange
- the guide wire may be either inserted into or at least partially withdrawn from the shaft 120 (e.g., in the distal portion 102 of the catheter 100 ) to transform the therapeutic assembly 110 between the delivery state 101 ( FIG. 1B ) and the deployed state 103 ( FIG. 1C ).
- a guide wire (not shown) extending through at least a portion of the length of the catheter 100 (e.g., through a lumen defined by the shaft 120 ) may be configured to straighten the pre-shaped spiral/helical control member 124 of the catheter 100 during delivery, and the guide wire may be at least partially withdrawn or slideably moved relative to the shaft 120 to allow the therapeutic assembly 110 to transform to the deployed state 103 ( FIG. 1C ).
- the spiral/helical therapeutic assembly 110 may have an outer diameter D of between about 4 mm and about 9 mm to accommodate, for example, blood vessel sizes having diameters in range of about 3 mm to about 8 mm.
- the control member 124 (shown schematically as a broken line) is itself pre-set into a spiral/helical shape. The dimensions of the spiral/helical shape of the control member 124 may be substantially the same as those of the spiral/helical therapeutic assembly 110 .
- the therapeutic assembly 110 does not include dedicated electrodes separate from the exposed portions 134 of the first wire 131 of the thermocouple assembly 130 , or any other conductors or bifilar wires that extend through the lumen or along the surface of the flexible tube 122 or elsewhere along the shaft 120 .
- the embodiment illustrated in FIGS. 1A-1C is configured to deliver neuromodulating energy to target tissue via the thermocouple assembly 130 .
- An advantage to this embodiment is that the additional manufacturing costs associated with adding separate electrodes and associated wiring of each individual electrode can be avoided while still delivering energy (e.g., RF energy) in suitable frequencies for desirably affecting the target tissue.
- one or more separate electrodes can be included in the therapeutic assembly 110 .
- a separately wired electrode can be positioned at any location along the length L 1 of the therapeutic assembly 110 to deliver the same or a different form of energy as that of the energy delivery portions 136 of the thermocouple assembly 130 .
- FIGS. 2A-2C illustrate assembly stages following steps in a method of forming a catheter apparatus 200 (“catheter 200 ”) having a therapeutic assembly 210 in a distal portion 202 of the catheter 200 for therapeutically modulating sympathetic nerves in accordance with another embodiment of the present technology.
- FIG. 2D is a perspective view of the distal portion 202 of the catheter 200 of FIG. 2C in a deployed state 203 (e.g., expanded configuration).
- the catheter 200 includes features generally similar to the features of the catheter 100 described above with reference to FIGS. 1A-1C .
- the distal portion 202 of the catheter 100 includes an elongated tubular shaft 220 , and includes a therapeutic assembly 210 having a thermocouple assembly 230 positioned about the shaft 220 .
- the thermocouple assembly 230 includes a junction 233 positioned proximal of a distal end 226 of the shaft 220 and includes a single exposed region 234 (e.g., an uninsulated region) of a first wire 231 that extends distal to the junction 233 and toward the distal end 226 .
- FIG. 2A is an enlarged cross-sectional side view of the therapeutic assembly 210 in a partially assembled state illustrating a stage in the assembly method after the thermocouple assembly 230 has been aligned with and positioned alongside the shaft 220 (e.g., in a distal portion 202 of the catheter 200 ).
- the shaft 220 can include a flexible tube 222 and a pre-shaped spiral/helical control member 224 within the tube 222 .
- FIG. 2A also illustrates a step in the process of arranging the thermocouple assembly 230 after an insulating portion has been removed from along the conductive first wire 231 in the region 234 between the junction 233 and an end 239 of the first wire 231 .
- the thermocouple assembly 230 also includes an insulated second wire 232 that terminates at the junction 233 .
- FIGS. 2B and 2C are enlarged, partial cross-sectional side views illustrating assembly stages following additional steps in the process for arranging the therapeutic assembly 210 of the catheter 200 shown in FIG. 2A .
- FIG. 2B illustrates a partially assembled stage in the process after the exposed region 234 of the first wire 231 has been helically positioned about the shaft 220 .
- the shaft 220 supports the exposed region 234 about an outer circumference of the distal portion of the shaft 220 and along a length L 2 of the therapeutic assembly 210 .
- FIG. 2B illustrates a partially assembled stage in the process after the exposed region 234 of the first wire 231 has been helically positioned about the shaft 220 .
- the shaft 220 supports the exposed region 234 about an outer circumference of the distal portion of the shaft 220 and along a length L 2 of the therapeutic assembly 210 .
- the exposed region 234 of the first wire 231 can be helically positioned (e.g., wound, wrapped, arranged, etc.) about the shaft 220 (e.g., in a distal portion 202 of the catheter 200 ) while the therapeutic assembly 210 is in the delivery state 201 .
- the thermocouple assembly 230 can be positioned about the shaft 220 to create a helical shape. A variety of helical or non-helical arrangements, however, are suitable for positioning the thermocouple assembly 230 on or about the shaft 220 .
- FIG. 2C illustrates a final assembly stage in the process after disposing one or more sleeves 250 composed of insulative material about portions of the first wire 231 and the shaft 220 (e.g., in a distal portion 202 of the catheter 200 ).
- the catheter 200 is in a delivery state 201 (e.g., low profile or collapsed configuration) in FIG. 2C .
- the one or more sleeves 250 can be placed along the therapeutic assembly 210 in positions aligned with the exposed region 234 of the first wire 231 to effectively disrupt the exposed region 234 .
- the portions of the first wire 231 that remain exposed can define a plurality of energy delivery portions 236 , which can deliver or otherwise transmit electrical energy (e.g., RF energy, pulsed energy, etc.) to target tissue in a manner similar to the energy delivery portions 136 described above with respect to FIGS. 1A-1C .
- the sleeves 250 may be equally spaced apart along the length L 2 of the therapeutic assembly 210 to define the plurality of energy delivery portions 236 .
- the number of energy delivery portions 236 can be four; however, in other embodiments, the number and arrangement of the energy delivery portions 236 may vary.
- the sleeves 250 can be a flexible and insulative material such as polyethylene terephthalate (PET) heat shrink tubing or other shrink tubing materials known in the art.
- PET polyethylene terephthalate
- the sleeves 250 can be composed of other polymer materials with or without additional insulative layers or materials.
- the sleeves 250 may comprise one or more of the following materials: polyamide; polyimide; polyether block amide copolymer sold under the trademark PEBAX; polypropylene; aliphatic, polycarbonate-based thermoplastic polyurethane sold under the trademark CARBOTHANE; or a polyether ether ketone (PEEK) polymer that provides the desired material properties.
- the sleeves 250 may be composed of other or additional suitable materials.
- the sleeves 250 are portions of tubing suitable to place over the distal end 226 of the shaft 220 and positioned at a further proximal site along the therapeutic assembly 210 .
- the sleeves 250 can be heat shrunk around the first wire 231 and the shaft 220 using known processes in the art, such that the exposed region 234 of the first wire 231 (e.g., the portion of the wire 231 after the insulating portion has been removed) is held in place (e.g., helically positioned about the shaft 220 ) and the sleeves 250 provide intermittently positioned insulated regions 235 along the first wire 231 to define the plurality of energy delivery portions 236 .
- adhesive (not shown) can be placed between an inner surface of the sleeves 250 and the shaft 220 (e.g., the flexible tube 222 ) to prevent blood from collecting and/or clotting between the sleeves 250 and the shaft 220 .
- the sleeves 250 can include material that is wrapped about the shaft 220 and secured into position using known mechanical fastening components or adhesive.
- FIG. 2D is a perspective view of the distal portion 202 of the catheter 200 of FIG. 2C in a deployed state 203 (e.g., expanded configuration) in accordance with an embodiment of the present technology.
- a deployed state 203 e.g., expanded configuration
- the control member 224 FIG.
- the thermocouple assembly 230 has a pre-set spiral/helical configuration that can define the deployed state 203 of the therapeutic assembly 210 such that the energy delivery portions 236 of the thermocouple assembly 230 are offset from each other (e.g., both angularly and circumferentially offset relative to a longitudinal axis of the artery and/or angularly offset from each other along an axis of the shaft 220 when the thermocouple assembly 210 is in the deployed configuration) and may be positioned in stable apposition with an inner surface of a wall of the artery (not shown) for treatment. Additionally, the energy delivery portions 236 along the first wire 231 are defined by the spacing between the sleeves 250 and are spaced apart from each other when the therapeutic assembly 210 is in the deployed state 203 .
- the energy delivery portions 236 are commonly connected to each other.
- the therapeutic assembly 210 can deliver neuromodulating energy from a power source (not shown) and through the thermocouple assembly 230 (e.g., through the first wire 231 ) to the target tissue via the energy delivery portions 236 .
- FIG. 3 illustrates a distal portion 302 of a catheter apparatus 300 (“catheter 300 ”) having a therapeutic assembly 310 or treatment section in a deployed state 303 (e.g., expanded configuration) in accordance with a further embodiment of the present technology.
- FIG. 3 is a perspective view of the distal portion 302 that includes features generally similar to the features of the catheters 100 , 200 described above with reference to FIGS. 1A-2D .
- the distal portion 302 of the catheter 100 includes an elongated tubular shaft 320 , and includes the therapeutic assembly 310 having a thermocouple assembly 330 positioned along the shaft 320 .
- the therapeutic assembly 310 having a thermocouple assembly 330
- thermocouple assembly 330 is not helically positioned about the shaft 320 ; rather, the thermocouple assembly 330 is positioned longitudinally along the shaft 320 (e.g., in the distal portion 302 of the shaft 320 ).
- the embodiment illustrated in FIG. 3 shows the thermocouple assembly 330 secured to the shaft 320 with one or more sleeves 350 , however, one of ordinary skill in the art will recognize that the thermocouple assembly 330 can be secured into position using other known mechanical fastening components (e.g., clips, collars, etc.) or adhesive.
- the embodiment illustrated in FIG. 3 includes the thermocouple assembly 330 having an arrangement similar to the thermocouple assembly arrangement shown in FIG. 1A .
- the thermocouple assembly 330 includes a conductive first wire 331 and a second wire 332 joined at a junction 333 at least proximate to a distal end 326 of the shaft 320 .
- the first and second wires 331 , 332 can be dissimilar metals and can include an insulative cover 337 over the wires, such as compacted mineral insulation and an outer sheath, or other appropriate conductive wire insulation known in the art.
- the conductive first wire 331 can relay and/or transmit an energy signal from an energy generating source (not shown), such as an RF energy generator located outside of the patient, and along a length of the conductive first wire 331 to the therapeutic assembly 310 .
- an energy generating source such as an RF energy generator located outside of the patient
- the thermocouple assembly 330 includes a plurality of exposed regions 334 (e.g., uninsulated regions) and insulated regions 335 along a portion of the first wire 331 to define a plurality of energy delivery portions 336 at the exposed regions 334 .
- the energy delivery portions 336 e.g., the exposed regions 334
- the energy delivery portions 336 are along the same conductive path and, accordingly, commonly connected with each other.
- the sleeves 350 can be positioned along the therapeutic assembly 310 to secure the thermocouple assembly 330 to the shaft 320 .
- the sleeves 350 can be similar to the sleeves 250 described above with respect to FIGS. 2C and 2D , or in another embodiment, the sleeves 350 may not include insulative properties, but serve to couple the thermocouple assembly 330 to the support structure 321 .
- a sleeve can perform both functions.
- the shaft 320 has a longitudinal axis or orientation, and the thermocouple assembly 330 extends at least generally parallel to the longitudinal axis of the shaft 320 .
- the therapeutic assembly 310 When deployed, the therapeutic assembly 310 has a pre-set spiral/helical configuration that defines the deployed state 303 of the therapeutic assembly 310 such that the energy delivery portions 336 of the thermocouple assembly 330 are both longitudinally offset (e.g., along the therapeutic assembly 310 ) and angularly or circumferentially offset (e.g., as defined by the spiral configuration of the shaft 320 ) from each other relative to a longitudinal axis of the artery. Accordingly, the energy delivery portions 336 may be positioned in stable apposition with an inner surface of a wall of the artery (not shown) for treatment.
- catheter device components described above and illustrated in FIGS. 1A-3 can be modified to form additional embodiments configured in accordance with the present technology.
- the catheter 100 illustrated in FIGS. 1A-1C and other catheter apparatuses described above and illustrated in FIG. 2A without sleeves can include sleeves that provide additional coupling of the first and/or second thermocouple wires to the shaft and/or provide additional insulation in selected regions where the sleeves are positioned.
- Further modifications of the therapeutic assembly 210 illustrated in FIG. 2B can include securing the exposed region 234 of the first wire 231 with non-insulating mechanical components such that a continuous helical lesion (rather than discrete lesions formed in a helical pattern; FIGS. 2C and 2D ) can be achieved.
- the catheters described above and illustrated in FIGS. 1A-3 can include one or more control members configured to receive one or more control wires (e.g., pull wires).
- a control wire can be used, for example, to control (e.g., deflect, angle, position, or steer) a distal portion of the shaft, a thermocouple assembly, or another catheter device component from outside the vasculature.
- FIG. 3 illustrates a therapeutic assembly having a non-helically positioned thermocouple assembly arrangement similar to the arrangement shown in FIG. 1A
- another embodiment of a catheter in accordance with the present technology could include a therapeutic assembly having a non-helically positioned thermocouple assembly arrangement similar to the arrangement shown in FIG. 2A and including a plurality of insulative sleeves to define energy delivery portions.
- the catheter apparatuses described above can also include additional thermocouple assemblies, electrode elements, wires, and energy delivery features positioned along the distal portion of the shaft.
- FIG. 4 is a partially schematic illustration of a neuromodulation system 400 (“system 400 ”) configured in accordance with an embodiment of the present technology.
- the system 400 includes an intravascular catheter 401 , which in various embodiments can be any of the catheters 100 ( FIGS. 1A-1C ), 200 ( FIGS. 2A-2D ), 300 ( FIG. 3 ), or another of the catheters described above, operably coupled to an energy source or energy generator 402 (e.g., an RF energy generator).
- the catheter 401 can include an elongated shaft 404 having a proximal portion 406 , a handle 408 at a proximal region of the proximal portion 406 , and a distal portion 410 .
- the catheter 401 can further include a therapeutic assembly or treatment section 412 (shown schematically) at the distal portion 410 (e.g., attached to the distal portion 410 , defining a section of the distal portion 410 , etc.).
- the therapeutic assembly 412 can include a support structure 414 and a thermocouple assembly 416 accompanying the support structure 414 . As discussed above with respect to the therapeutic assemblies of the catheter devices illustrated in FIGS.
- the thermocouple assembly 416 can have an energy delivery wire (e.g., a first wire) having one or more exposed regions that define one or more energy delivery portions 418 along the length of the therapeutic assembly 412 and which is configured to be delivered to a target blood vessel (e.g., an artery, vein or ostium) in a low-profile configuration.
- a target blood vessel e.g., an artery, vein or ostium
- targeted blood vessels can include, for example, a renal artery, an ovarian artery, testicular artery, external iliac artery, internal iliac artery, internal pudendal artery, uterine artery, celiac artery, superior mesenteric artery, hepatic artery, splenic artery, gastric artery, pancreatic artery, and/or associated arterial branches.
- a renal artery an ovarian artery
- testicular artery external iliac artery
- internal iliac artery internal pudendal artery
- uterine artery celiac artery
- superior mesenteric artery hepatic artery
- splenic artery gastric artery
- pancreatic artery pancreatic artery
- the therapeutic assembly 412 Upon delivery to the target treatment site within the target blood vessel (e.g., renal blood vessel), the therapeutic assembly 412 is further configured to be deployed into an expanded state (e.g., a generally spiral/helical configuration, an expanded lasso or J-shaped configuration, etc.) for delivering energy at the treatment site and providing therapeutically-effective thermally-induced neuromodulation.
- the deployed state may be non-spiral provided that the deployed state provides adequate contact between energy delivery portions and the inner surface of the vessel wall.
- the therapeutic assembly 412 may be transformed between the delivery and deployed states using a variety of suitable mechanisms or techniques (e.g., self-expansion, remote actuation via an actuator, etc.).
- the neuromodulation assembly 412 may be placed or transformed into the deployed state or arrangement via remote actuation, e.g., via an actuator 409 , such as a knob, pin, or lever carried by the handle 408 .
- an actuator 409 such as a knob, pin, or lever carried by the handle 408 .
- advancement of a pre-shaped or expandable element or wire e.g., a Nitinol wire
- a pre-shaped or expandable element or wire e.g., a Nitinol wire
- the proximal end of the therapeutic assembly 412 is carried by or affixed to the distal portion 410 of the elongated shaft 404 .
- a distal end of the therapeutic assembly 412 may terminate the catheter 401 with, for example, an atraumatic tip 420 .
- the distal end of the therapeutic assembly 412 may also be configured to engage another element of the system 400 or catheter 401 .
- the distal end of the therapeutic assembly 412 may define a passageway for receiving a guide wire (not shown) for delivery of the treatment device using OTW or rapid exchange (“RX”) techniques. Further details regarding such arrangements are described below.
- the catheter 401 can be electrically coupled to the energy source 402 via a cable 430 , and the energy source 402 (e.g., an RF energy generator) can be configured to produce a selected modality and magnitude of energy for delivery to the treatment site via the thermocouple assembly's energy delivery portions 418 along the first wire.
- the energy source 402 e.g., an RF energy generator
- thermocouple wires can extend along the elongated shaft 404 or through a lumen in the shaft 404 to the therapeutic assembly 412 at the distal portion 410 of the elongated shaft 404 and transmit the treatment energy to the energy delivery portions 418 (e.g., the exposed regions of the energy delivering thermocouple wire).
- each energy delivery portion 418 can receive and deliver energy supplied by the single energy delivery wire within the thermocouple assembly 416 instead of each portion 418 having its own supply wire.
- the energy delivery portions 418 are positioned along the same electrical power wire or line, and accordingly, deliver power in a simultaneous fashion.
- a control mechanism 432 such as a foot pedal or handheld remote control device, may be connected to the energy source 402 to allow the clinician to initiate, terminate and, optionally, adjust various operational characteristics of the energy source 402 , including, but not limited to, power delivery.
- the remote control device (not shown) can be positioned in a sterile field and operably coupled to the thermocouple assembly, and specifically to the energy delivering thermocouple wire having the exposed (e.g., uninsulated) energy delivery portions 418 , and can be configured to allow the clinician to activate and deactivate the energy delivery to the energy delivery portions 418 .
- the remote control device may be built into the handle assembly 408 .
- the energy source or energy generator 402 can be configured to deliver the treatment energy via an automated control algorithm 434 and/or under the control of a clinician.
- the energy source 402 can include computing devices (e.g., personal computers, server computers, tablets, etc.) having processing circuitry (e.g., a microprocessor) that is configured to execute stored instructions relating to the control algorithm 434 .
- the processing circuitry may be configured to execute one or more evaluation/feedback algorithms 435 , which can be communicated to the clinician.
- the energy source 402 can include a monitor or display 436 and/or associated features that are configured to provide visual, audio, or other indications of power levels, sensor data, and/or other feedback.
- the energy source 402 can also be configured to communicate the feedback and other information to another device, such as a monitor in a catheterization laboratory.
- the system 400 may be configured to provide delivery of a monopolar electric field via the energy delivery portions 418 .
- a neutral or dispersive electrode 438 may be electrically connected to the energy generator 402 and attached to the exterior of the patient (as shown in FIG. 5 ).
- the individual energy delivery portions e.g., energy delivery portions 136 , 236 and 336 from FIGS. 1A-3 ) are connected to the energy generator 402 and are sized and configured to contact an internal wall of the artery (e.g., the renal artery).
- the energy delivery portions may be operated in a monopolar or unipolar mode.
- a return path for the applied RF electric field is established, e.g., by the external dispersive electrode 438 , also called an indifferent electrode or neutral electrode.
- the monopolar application of RF electric field energy serves to ohmically or resistively heat tissue in the vicinity of the electrode.
- the application of the RF electrical field thermally injures tissue.
- the treatment objective is to thermally induce neuromodulation (e.g., necrosis, thermal alteration or ablation) in the targeted neural fibers.
- the thermal injury forms a lesion in the vessel wall.
- an RF electrical field may be delivered with an oscillating or pulsed intensity that does not thermally injure the tissue whereby neuromodulation in the targeted nerves is accomplished by electrical modification of the nerve signals.
- the system 400 can also include one or more additional sensors (not shown) located proximate to or within the energy delivery portions 418 .
- the system 400 can include one or more other temperature sensors (e.g., one or more additional thermocouples, thermistors, etc.), impedance sensors, pressure sensors, optical sensors, flow sensors, and/or other suitable sensors connected to one or more supply wires (not shown) that transmit signals from the sensors and/or convey energy to the therapeutic assembly 412 .
- FIG. 5 illustrates modulating renal nerves with an embodiment of the system 400 .
- the catheter 401 provides access to the renal plexus RP through an intravascular path P, such as a percutaneous access site in the femoral (illustrated), brachial, radial, or axillary artery to a targeted treatment site within a respective renal artery RA.
- an intravascular path P such as a percutaneous access site in the femoral (illustrated), brachial, radial, or axillary artery to a targeted treatment site within a respective renal artery RA.
- a section of the proximal portion 406 of the shaft 404 is exposed externally of the patient.
- the clinician may advance the shaft 404 through the sometimes tortuous intravascular path P and remotely manipulate the distal portion 410 of the shaft 404 .
- FIG. 1 illustrates modulating renal nerves with an embodiment of the system 400 .
- the therapeutic assembly 412 is delivered intravascularly to the treatment site using a guide wire 440 in an OTW technique.
- the distal end of the therapeutic assembly 412 may define a lumen or passageway for receiving the guide wire 440 for delivery of the catheter 401 using either OTW or RX techniques.
- the guide wire 401 can be at least partially axially withdrawn or removed, and the therapeutic assembly 412 can transform or otherwise be moved to a deployed arrangement for delivering energy at the treatment site as described above with respect to FIGS. 1A-3 .
- the guide wire 440 may comprise any suitable medical guide wire sized to slideably fit within the lumen. In one particular embodiment, for example, the guide wire 440 may have a diameter of 0.356 mm (0.014 inch).
- the therapeutic assembly 412 may be delivered to the treatment site within a guide sheath (not shown) with or without using the guide wire 440 .
- the guide sheath may be at least partially withdrawn or retracted and the therapeutic assembly 412 can be transformed into the deployed arrangement.
- the shaft 404 may be steerable itself such that the therapeutic assembly 412 may be delivered to the treatment site without the aid of the guide wire 440 and/or guide sheath.
- Image guidance e.g., computed tomography (CT), fluoroscopy, intravascular ultrasound (IVUS), optical coherence tomography (OCT), intracardiac echocardiography (ICE), or another suitable guidance modality, or combinations thereof, may be used to aid the clinician's positioning and manipulation of the therapeutic assembly 412 .
- a fluoroscopy system e.g., including a flat-panel detector, x-ray, or c-arm
- the treatment site can be determined using IVUS, OCT, and/or other suitable image mapping modalities that can correlate the target treatment site with an identifiable anatomical structure (e.g., a spinal feature) and/or a radiopaque ruler (e.g., positioned under or on the patient) before delivering the catheter 401 .
- image guidance components e.g., IVUS, OCT
- image guidance components e.g., IVUS or OCT
- IVUS intravascular medical apparatus
- OCT optical coherence tomography
- the purposeful application of energy from the energy delivery portions 418 may be applied to target tissue to induce one or more desired neuromodulating effects on localized regions of the renal artery and adjacent regions of the renal plexus RP, which lay intimately within, adjacent to, or in close proximity to the adventitia of the renal artery RA.
- the purposeful application of the energy may achieve neuromodulation along all or at least a portion of the renal plexus RP.
- the neuromodulating effects are generally a function of, at least in part, power, time, contact between the energy delivery portions 418 ( FIG. 4 ) and the vessel wall, and blood flow through the vessel.
- the neuromodulating effects may include denervation, thermal ablation, and/or non-ablative thermal alteration or damage (e.g., via sustained heating and/or resistive heating).
- Desired thermal heating effects may include raising the temperature of target neural fibers above a desired threshold to achieve non-ablative thermal alteration, or above a higher temperature to achieve ablative thermal alteration.
- the target temperature may be above body temperature (e.g., approximately 37° C.) but less than about 45° C. for non-ablative thermal alteration, or the target temperature may be about 45° C. or higher for the ablative thermal alteration.
- Desired non-thermal neuromodulation effects may include altering the electrical signals transmitted in a nerve.
- the therapeutic assembly 412 may be transformed from its delivery state (e.g., delivery state 101 shown in FIG. 1B ) to its deployed state (e.g., deployed state 103 shown in FIG. 1C ).
- the transformation may be initiated using an arrangement of device components as described herein with respect to the particular embodiments and their various modes of deployment.
- the therapeutic assembly 412 may be deployed by retracting the guide wire 440 until a distal tip of the guide wire 440 is generally aligned with the tip 420 of the catheter 401 .
- the guide wire 440 may have a varying stiffness or flexibility along its length so as to provide increased flexibility distally.
- the pre-set spiral shape of the control member 124 FIG. 1A
- the guide wire 440 can impart additional structural integrity to the spiral-shaped portion during treatment. This feature is expected to help mitigate or reduce problems associated with keeping the therapeutic assembly 412 in place during treatment (e.g., help with vasoconstriction).
- the guide wire 440 may have a stiffness profile that permits the distal portion of the guide wire 440 to remain extended from an opening (not shown) in the tip 420 while still permitting the therapeutic assembly 412 to transform to its deployed state (e.g., deployed state 103 shown in FIG. 1C ).
- the guide wire 440 may be withdrawn completely from the therapeutic assembly 412 (e.g., a distalmost end portion of the guide wire 440 is proximal of the therapeutic assembly 412 ) to permit the transformation, while a distalmost portion of the guide wire 440 remains within the shaft 404 .
- the guide wire 440 may be withdrawn completely from the shaft 404 .
- the clinician can withdraw the guide wire 440 sufficiently to observe transformation of the therapeutic assembly 412 to the deployed configuration and/or until an X-ray image shows that the distal tip of the guide wire 440 is at a desired location relative to the therapeutic assembly 412 (e.g., generally aligned with the tip 420 , completely withdrawn from the therapeutic assembly 412 , etc.).
- the extent of withdrawal for the guide wire 440 can be based, at least in part, on the clinician's judgment with respect to the selected guide wire and the extent of withdrawal necessary to achieve deployment.
- the therapeutic assembly 412 may be transformed back to the low-profile delivery configuration by axially advancing the guide wire 440 relative to the therapeutic assembly 412 .
- the guide wire 440 may be advanced until the distal tip of the guide wire 440 is generally aligned with the tip 420 , and the catheter 401 can then be pulled back over the stationary guide wire 440 .
- the distalmost portion of the guide wire 440 may be advanced to a different location relative to the therapeutic assembly 412 to achieve transformation of the therapeutic assembly 412 back to a low-profile arrangement.
- Neuromodulation is the partial or complete incapacitation or other effective disruption of nerves innervating, for example, an organ.
- renal neuromodulation is the partial or complete incapacitation or other effective disruption of nerves innervating the kidneys.
- renal neuromodulation comprises inhibiting, reducing, and/or blocking neural communication along neural fibers (i.e., efferent and/or afferent nerve fibers) innervating the kidneys.
- Such incapacitation can be long-term (e.g., permanent or for periods of months, years, or decades) or short-term (e.g., for periods of minutes, hours, days, or weeks).
- Renal neuromodulation is expected to efficaciously treat several clinical conditions characterized by increased overall sympathetic activity, and in particular conditions associated with central sympathetic over-stimulation such as hypertension, heart failure, acute myocardial infarction, metabolic syndrome, insulin resistance, diabetes, left ventricular hypertrophy, chronic and end stage renal disease, inappropriate fluid retention in heart failure, cardio-renal syndrome, osteoporosis, and sudden death.
- the reduction of afferent neural signals contributes to the systemic reduction of sympathetic tone/drive, and renal neuromodulation is expected to be useful in treating several conditions associated with systemic sympathetic over activity or hyperactivity. Renal neuromodulation can potentially benefit a variety of organs and bodily structures innervated by sympathetic nerves.
- Various techniques can be used to partially or completely incapacitate neural pathways, such as those innervating the kidney.
- energy e.g., electrical energy, thermal energy
- the purposeful application of energy (e.g., electrical energy, thermal energy) to tissue by energy delivery element(s) or components such as those described in conjunction with the catheter devices above, can induce one or more desired thermal heating effects on localized regions of the renal artery and adjacent regions of the renal plexus, which lay intimately within or adjacent to the adventitia of the renal artery.
- the purposeful application of the thermal heating effects can achieve neuromodulation along all or a portion of the renal plexus.
- the thermal heating effects can include both thermal ablation and non-ablative thermal alteration or damage (e.g., via sustained heating and/or resistive heating). Desired thermal heating effects may include raising the temperature of target neural fibers above a desired threshold to achieve non-ablative thermal alteration, or above a higher temperature to achieve ablative thermal alteration.
- the target temperature can be above body temperature (e.g., approximately 37° C.) but less than about 45° C. for non-ablative thermal alteration, or the target temperature can be about 45° C. or higher for the ablative thermal alteration.
- thermal energy in excess of a body temperature of about 37° C., but below a temperature of about 45° C.
- thermal energy in excess of a body temperature of about 37° C., but below a temperature of about 45° C.
- the target neural fibers are denied perfusion resulting in necrosis of the neural tissue.
- this may induce non-ablative thermal alteration in the fibers or structures.
- Exposure to heat above a temperature of about 45° C., or above about 60° C. may induce thermal alteration via substantial heating of the fibers or structures. For example, such higher temperatures may thermally ablate the target neural fibers or the vascular structures.
- RSNA renal sympathetic nerve activity
- a method of manufacturing a medical device for neuromodulation comprising:
- the shaft comprises a tubular structure having a lumen therethrough and is composed of a Nitinol multifilar stranded wire.
- thermocouple assembly 6. The method of any one of examples 1-5 wherein the exposed regions along the first wire of the thermocouple assembly are in electrical communication with each other.
- thermocouple assembly 7. The method of any one of examples 1-6, further comprising selectively removing portions of the first wire of the thermocouple assembly to define a plurality of exposed and insulated regions.
- thermocouple assembly comprises forming four exposed regions along the first wire.
- thermocouple assembly comprises a radially expanded, generally spiral shape configured to contact the wall of the blood vessel and to allow blood to flow through the vessel.
- a catheter apparatus comprising:
- thermocouple assembly do not contact each other in the delivery or deployed configurations.
- thermocouple assembly comprises four energy delivery portions.
- a catheter system comprising:
Abstract
Catheter apparatuses, systems, and methods for achieving neuromodulation by intravascular access are disclosed herein. One aspect of the present technology, for example, is directed to a treatment device having a therapeutic assembly that includes an elongated tubular shaft having a pre-formed spiral shape when in a deployed state (e.g., a radially expanded, generally spiral/helical shape) and a thermocouple assembly helically wrapped about the shaft. In one embodiment, the thermocouple assembly comprises first and second wires composed of dissimilar metals with the first wire including a plurality of exposed and insulated regions along the distal portion of the treatment device. The exposed regions of the first wire define a plurality of energy delivery portions positioned to deliver electrical energy (e.g., RF energy, pulsed energy, etc.) to target tissue adjacent a wall of an artery (e.g., a renal artery) to heat or otherwise electrically modulate neural fibers that contribute to physiological function (e.g., renal function).
Description
- The present technology relates generally to neuromodulation and associated systems and methods. In particular, several embodiments are directed to catheters having energy delivering thermocouple assemblies for intravascular neuromodulation and associated systems and methods.
- The sympathetic nervous system (SNS) is a primarily involuntary bodily control system typically associated with stress responses. Fibers of the SNS innervate tissue in almost every organ system of the human body and can affect characteristics such as pupil diameter, gut motility, and urinary output. Such regulation can have adaptive utility in maintaining homeostasis or preparing the body for rapid response to environmental factors. Chronic activation of the SNS, however, is a common maladaptive response that can drive the progression of many disease states. Excessive activation of the renal SNS in particular has been identified experimentally and in humans as a likely contributor to the complex pathophysiology of hypertension, states of volume overload (such as heart failure), and progressive renal disease. For example, radiotracer dilution has demonstrated increased renal norepinephrine (“NE”) spillover rates in patients with essential hypertension.
- Cardio-renal sympathetic nerve hyperactivity can be particularly pronounced in patients with heart failure. For example, an exaggerated NE overflow from the heart and kidneys to plasma is often found in these patients. Heightened SNS activation commonly characterizes both chronic and end stage renal disease. In patients with end stage renal disease, NE plasma levels above the median have been demonstrated to be predictive of cardiovascular diseases and several causes of death. This is also true for patients suffering from diabetic or contrast nephropathy. Evidence suggests that sensory afferent signals originating from diseased kidneys are major contributors to initiating and sustaining elevated central sympathetic outflow.
- Sympathetic nerves innervating the kidneys terminate in the blood vessels, the juxtaglomerular apparatus, and the renal tubules. Stimulation of the renal sympathetic nerves can cause increased renin release, increased sodium (Na+) reabsorption, and a reduction of renal blood flow. These neural regulation components of renal function are considerably stimulated in disease states characterized by heightened sympathetic tone and likely contribute to increased blood pressure in hypertensive patients. The reduction of renal blood flow and glomerular filtration rate as a result of renal sympathetic efferent stimulation is likely a cornerstone of the loss of renal function in cardio-renal syndrome (i.e., renal dysfunction as a progressive complication of chronic heart failure). Pharmacologic strategies to thwart the consequences of renal efferent sympathetic stimulation include centrally acting sympatholytic drugs, beta blockers (intended to reduce renin release), angiotensin converting enzyme inhibitors and receptor blockers (intended to block the action of angiotensin II and aldosterone activation consequent to renin release), and diuretics (intended to counter the renal sympathetic mediated sodium and water retention). These pharmacologic strategies, however, have significant limitations including limited efficacy, compliance issues, side effects, and others. Recently, intravascular devices that reduce sympathetic nerve activity by applying an energy field to a target site in the renal blood vessel (e.g., via radiofrequency ablation) have been shown to reduce blood pressure in patients with treatment-resistant hypertension.
- Many aspects of the present disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale. Instead, emphasis is placed on illustrating clearly the principles of the present disclosure. Furthermore, components can be shown as transparent in certain views for clarity of illustration only and not to indicate that the illustrated component is necessarily transparent. For ease of reference, throughout this disclosure identical reference numbers may be used to identify identical or at least generally similar or analogous components or features.
-
FIG. 1A is an enlarged cross-sectional side view illustrating a therapeutic assembly of a neuromodulation catheter apparatus following a step in a process for assembling the therapeutic assembly from an unassembled state outside a patient in accordance with an embodiment of the present technology. -
FIG. 1B is a side view of the therapeutic assembly of the catheter apparatus shown inFIG. 1A , following another step in the assembly process of the therapeutic assembly, with the therapeutic assembly shown in a delivery state (e.g., low-profile or collapsed configuration) in accordance with an embodiment of the present technology. -
FIG. 1C is a perspective view of the distal portion of the catheter apparatus ofFIG. 1B in a deployed state (e.g., expanded configuration) in accordance with an embodiment of the present technology. -
FIG. 1D is a partially schematic side view of the distal portion of the catheter apparatus ofFIG. 1C in the deployed state. -
FIG. 2A is an enlarged cross-sectional side view illustrating a therapeutic assembly of a neuromodulation catheter apparatus following a step in a process for assembling the therapeutic assembly from an unassembled state outside a patient in accordance with another embodiment of the present technology. -
FIGS. 2B and 2C are enlarged, partial cross-sectional side views illustrating assembly stages following additional steps in the process for making the therapeutic assembly of the catheter apparatus shown inFIG. 2A in accordance with embodiments of the present technology. -
FIG. 2D is a perspective view of the distal portion of the catheter apparatus ofFIG. 2C in a deployed state (e.g., expanded configuration) in accordance with an embodiment of the present technology. -
FIG. 3 is a perspective view of a distal portion of a catheter having a therapeutic assembly or treatment section in a deployed state (e.g., expanded configuration) in accordance with a further embodiment of the present technology. -
FIG. 4 is a partially schematic diagram of a neuromodulation system configured in accordance with an embodiment of the present technology. -
FIG. 5 illustrates modulating renal nerves with a catheter apparatus configured in accordance with an embodiment of the present technology. - The present technology is directed to apparatuses, systems, and methods for achieving thermally-induced neuromodulation (i.e., rendering neural fibers that innervate, for example, the kidney or another physiological organ or structure inert or inactive or otherwise completely or partially reduced in function) by percutaneous transluminal intravascular access. In particular, embodiments of the present technology relate to catheters and catheter assemblies having energy delivering thermocouple assemblies and being movable between a delivery or low-profile state (e.g., a generally straight shape) and a deployed state (e.g., a radially expanded shape, generally spiral/helical shape, an expanded lasso shape, J-shape, etc.). The thermocouple assembly may include a plurality of non-insulated energy-delivery portions of a first thermocouple wire (e.g., a silver-coated nickel wire, a silver wire, a nickel wire, a copper wire with biocompatible coating thereon, etc.) that can be coupled to or otherwise extend along or about a longitudinal dimension of a catheter shaft, and may include a second insulated thermocouple wire (e.g., a constantan wire) for thermocouple functionality. The thermocouple assembly is in electrical communication with an energy source or energy generator such that energy is delivered from the non-insulated energy delivery portions of the first thermocouple wire to portions of an artery after being advanced thereto via a catheter along a percutaneous transluminal path (e.g., a femoral artery puncture, an iliac artery and the aorta, a radial artery, or another suitable intravascular path). Any suitable energy modality may be used (e.g., electrical energy such as radiofrequency (RF) energy, pulsed energy, etc.). The catheter or catheter assembly carrying the thermocouple assembly may be sized and shaped so that the non-insulated energy delivery portions contact an interior wall of an artery (e.g., a renal artery, an ovarian artery, testicular artery, external iliac artery, internal iliac artery, internal pudendal artery, uterine artery, celiac artery, superior mesenteric artery, hepatic artery, splenic artery, gastric artery, pancreatic artery, and/or associated arterial branches, etc.) when the catheter is in the deployed state within the artery. The pre-formed expanded shape (e.g., spiral/helical, lasso, J-shape, etc.) of the deployed portion of the catheter carrying the thermocouple assembly allows blood to flow through the helix, which is expected to help avoid occlusion of the artery during activation of the non-insulated energy delivery portions of the thermocouple wire.
- Energy-delivery catheter systems for inducing neuromodulation that include separate electrodes or arrays of electrodes can be expensive to manufacture. These designs may require separate wiring of each electrode to a conventional thermocouple wire, as well as complex algorithms and energy generator designs to operate. In contrast, the thermocouple assembly presented herein includes a single energy delivering wire (e.g., the first wire) that can have direct electrical communication with an energy generator, and each non-insulated energy delivery portion of the single wire is in electrical communication with each of the other non-insulated energy delivery portions along the wire. This is expected to reduce manufacturing time and material costs associated with separate electrodes and wiring, as well as reduce the complexity of the control algorithm typically necessary to operate more than one independent electrode or energy delivery element.
- Specific details of several embodiments of the technology are described below with reference to
FIGS. 1A-5 . Although many of the embodiments are described below with respect to devices, systems, and methods for intravascular modulation of sympathetic nerves using thermocouple assemblies, other applications and other embodiments in addition to those described herein are within the scope of the technology. Additionally, several other embodiments of the technology can have different configurations, components, or procedures than those described herein. A person of ordinary skill in the art, therefore, will accordingly understand that the technology can have other embodiments with additional elements, or the technology can have other embodiments without several of the features shown and described below with reference toFIGS. 1A-5 . - As used herein, the terms “distal” and “proximal” define a position or direction with respect to the treating clinician or clinician's control device (e.g., a handle assembly). “Distal” or “distally” are a position distant from or in a direction away from the clinician or clinician's control device. “Proximal” and “proximally” are a position near or in a direction toward the clinician or clinician's control device.
-
FIGS. 1A and 1B illustrate assembly stages following steps in a method of forming a catheter apparatus 100 (“catheter 100”) having atherapeutic assembly 110 in adistal portion 102 of thecatheter 100 for therapeutically modulating sympathetic nerves in a patient in accordance with an embodiment of the present technology.FIG. 1C is a perspective view of thedistal portion 102 of thecatheter 100 ofFIG. 1B in a deployed state 103 (e.g., expanded configuration). Referring toFIGS. 1A-1C together, thedistal portion 102 includes an elongatedtubular shaft 120, and thetherapeutic assembly 110 can include theshaft 120 and athermocouple assembly 130 positioned along theshaft 120. Thetherapeutic assembly 110 can be transformed or actuated between a delivery state 101 (e.g., a low-profile or collapsed configuration,FIG. 1B ) and the deployed state 103 (e.g., a radially expanded, generally spiral configuration,FIG. 1C ) in which thetherapeutic assembly 110 is configured to contact a wall of a blood vessel (e.g., a renal blood vessel). - Referring back to
FIGS. 1A and 1B , thetherapeutic assembly 110 of thecatheter 100 is shown in various stages of assembly for forming thecatheter apparatus 100 in a delivery state 101 (e.g., low-profile or collapsed configuration) outside of a patient. As best seen inFIG. 1A , theshaft 120 can include aflexible tube 122 and a pre-shaped spiral/helical control member 124 within thetube 122. Theflexible tube 122 may be composed of a polymer material such as: polyamide; polyimide; polyether block amide copolymer sold under the trademark PEBAX; polyethylene terephthalate (PET); polypropylene; aliphatic, polycarbonate-based thermoplastic polyurethane sold under the trademark CARBOTHANE; or a polyether ether ketone (PEEK) polymer that provides the desired flexibility. In other embodiments, however, thetube 122 may be composed of other suitable materials. - As mentioned above, the
pre-shaped control member 124 may be used to provide a spiral/helical shape to theshaft 120 in thedistal portion 102 of thecatheter 100. In one embodiment, thecontrol member 124 can be a tubular structure comprising a nitinol multifilar stranded wire with a lumen therethrough and sold under the trademark HELICAL HOLLOW STRAND (HHS), and commercially available from Fort Wayne Metals of Fort Wayne, Ind. Thetubular control member 124 may be formed from a variety of different types of materials, may be arranged in a single or dual-layer configuration, and may be manufactured with a selected tension, compression, torque and pitch direction. The HHS material, for example, may be cut using a laser, electrical discharge machining (EDM), electrochemical grinding (ECG), or other suitable means to achieve a desired finished component length and geometry. - Forming the
control member 124 of Nitinol multifilar stranded wire(s) or other similar materials is expected to provide a desired level of support and rigidity to thetherapeutic assembly 110 without additional reinforcement wire(s) or other reinforcement features within theshaft 120. This feature is expected to reduce the number of manufacturing processes required to form thecatheter 100 and reduce the number of materials required for the device. In one embodiment, thecontrol member 124 and inner wall of thetube 122 can be in intimate contact with little or no space between thecontrol member 124 and thetube 122. In some embodiments, for example, thetube 122 can have a larger diameter than thecontrol member 124 prior to assembly such that applying hot air to thetube 122 during the manufacturing process shrinks the tube onto thecontrol member 124, as will be understood by those familiar with the ordinary use of shrink tubing materials. This feature is expected to inhibit or eliminate wrinkles or kinks that might occur in thetube 122 as thetherapeutic assembly 110 transforms from the relativelystraight delivery state 101 to the deployed, generally spiral state 103 (FIG. 1C ). - In other embodiments, the
control member 124 and/or other components of the shaft 120 (e.g., in thedistal portion 102 of the catheter 100) may be composed of different materials and/or have a different arrangement. For example, thecontrol member 124 may be formed from other suitable shape memory materials (e.g., nickel-titanium (Nitinol), wire or tubing besides HHS, shape memory polymers, electro-active polymers) that are pre-formed or pre-shaped into the desired deployed state. Alternatively, thecontrol member 124 may be formed from multiple materials such as a composite of one or more polymers and metals. -
FIG. 1A illustrates a stage in the method of forming thetherapeutic assembly 110 in thedistal portion 102 of thecatheter 100 after thethermocouple assembly 130 has been aligned with and positioned alongside theshaft 120. In the embodiment shown inFIG. 1A , thethermocouple assembly 130 includes a conductivefirst wire 131 and asecond wire 132 joined at ajunction 133 at least proximate to theshaft 120. The first andsecond wires second wires insulative cover 137, such as compacted mineral insulation and an outer sheath, or other appropriate conductive wire insulation known in the art. In one embodiment, the conductivefirst wire 131 can include an insulated energy delivery or transmitting wire that can relay and/or transmit an energy signal from an energy source (not shown), such as an RF energy generator located outside of the patient. In one embodiment, RF signals can be transmitted along a length of the conductivefirst wire 131 to thetherapeutic assembly 110. -
FIG. 1A also shows a stage in the method after selected portions of the insulatingcover 137 have been removed from along the conductivefirst wire 131 to form a plurality of exposed regions 134 (e.g., uninsulated regions) separated from each other byinsulated regions 135 along a portion of thefirst wire 131 proximate the shaft 120 (e.g., in thedistal portion 102 of the catheter 100). The exposedregions 134 of the conductivefirst wire 131 can define a plurality of energy delivery portions 136 a-136 d (referred to collectively as energy delivery portions 136) configured to deliver electrical energy (e.g., RF energy, pulsed energy, etc.) to target tissue. In this embodiment, the energy delivery portions 136 (e.g., the exposed regions 134) are along the same conductive path and, accordingly, commonly connected to an energy source. Thethermocouple assembly 130 can include more than one exposedregion 134 along thefirst wire 131. For example thethermocouple assembly 130 can include between 2 and about 8 exposedregions 134 along thefirst wire 131, or between 2 and about 6 exposedregions 134, or between 2 and about 4 exposedregions 134, or about 4 exposedregions 134. In some embodiments, the energy delivery portions 136 a-136 d may be equally spaced apart along a length L1 of thetherapeutic assembly 110. In other embodiments, however, the number, size and arrangement (e.g., spacing) of the energy delivery portions 136 may vary. For example, a firstenergy delivery portion 136 a may have a first size (e.g., a first length) and a secondenergy delivery portion 136 b may have a second size (e.g., a second length) different than the first size, and/or first and secondenergy delivery portions energy delivery portions - The
thermocouple assembly 130 can also include thesecond wire 132, which can be a wire that is at least insulated along theshaft 120. Thesecond wire 132 can run parallel to thefirst wire 131 and can be electrically coupled to thejunction 133. Thefirst wire 131 and thesecond wire 132 include dissimilar metals such that the electric potential between the twowires junction 133 relates to a temperature reading at the junction (e.g., at the therapeutic assembly 110). In one embodiment, thefirst wire 131 comprises a conductive material, such as nickel, silver, or in another embodiment, silver-coated nickel. In some embodiments, the conductivefirst wire 131 and/or the exposedregions 134 of thefirst wire 131 can be coated with a biocompatible conductive material (not shown), such as gold or platinum. In some embodiments, a non-biocompatible material (e.g., copper) may be used, for example in a Type T thermocouple or other non-biocompatible thermocouple, along with a biocompatible conductive material such as gold or platinum (e.g., coating for the non-biocompatible materials). Biocompatible materials and/or coatings, however, can be used with any of thethermocouple assemblies 130 described herein. Additional intermediate bonding materials (e.g., tantalum, titanium, etc.) may also be included. In various embodiments, thesecond wire 132 can be an insulated constantan wire. In a specific embodiment, thethermocouple assembly 130 can be a Type T thermocouple and thefirst wire 131 can be copper (e.g., gold or platinum coated copper) and thesecond wire 132 can be constantan. In this example, thethermocouple assembly 130 can measure temperatures in the temperature range of about −200° C. to about 350° C. -
FIG. 1B illustrates a stage in the method after thethermocouple assembly 130 has been helically/spirally positioned about the shaft 120 (e.g., in thedistal portion 102 of the catheter 100). In this embodiment, theshaft 120 supports thethermocouple assembly 130 about an outer circumference of the distal portion of thecatheter 100 and along a length L1 of thetherapeutic assembly 110. As shown inFIG. 1B , thethermocouple assembly 130 can be helically positioned (e.g., wound, wrapped, arranged, etc.) about the shaft 120 (e.g., in thedistal portion 102 of the catheter 100) while thetherapeutic assembly 110 is in thedelivery state 101. In one example, thethermocouple assembly 130 can be positioned about theshaft 120 to create a helical shape; however, a variety of helical or non-helical arrangements are suitable for positioning thethermocouple assembly 130 on or about theshaft 120. In some embodiments, thethermocouple assembly 130 may have a pitch of about 1 mm to 12 mm. In other embodiments, however, thethermocouple assembly 130 may have different dimensions. - The
thermocouple assembly 130 may be coupled or attached to the shaft 120 (e.g., attached to the flexible tube 122) at one or more locations along theshaft 120 using adhesives (e.g., thermal bonds), fasteners, and/or other suitable attachment mechanisms known in the art (e.g., clips, ties, staples, collars, etc.). In one embodiment, thetherapeutic assembly 110 can include proximal and distal connectors or retainers (not shown), such as collars or other suitable fasteners to which proximal and distal portions of thethermocouple assembly 130, respectively, may be attached. In such arrangements, the first andsecond wires shaft 120 between the proximal and distal connectors (not shown). In various arrangements, such connectors may be attached over select portions of theshaft 120, thereby coupling thethermocouple assembly 130 to theshaft 120. The connectors can be attached to theshaft 120, for example, using thermal bonds, adhesives, interlocking surfaces (e.g., threads), friction fit, snap fit, suction, and/or other suitable attachment mechanisms, or the connectors can be formed integrally with thethermocouple assembly 130 and/or theshaft 120. In other embodiments, thetherapeutic assembly 110 does not include additional connectors or attachment means, but can be retained against theshaft 120 with a guide sheath or loading tool (not shown) that is moved over the length L1 of thetherapeutic assembly 110 during advancement and retrieval. - The
junction 133 of thethermocouple assembly 130 can be positioned at a distal end of thetherapeutic assembly 110 which may or may not be adistal end 126 of the shaft 120 (FIGS. 1B and 1C ). In one example, thecatheter 100 terminates at anatraumatic tip 128 at thedistal end 126 of the shaft 120 (FIG. 1B ). Theatraumatic tip 128 can be a flexible curved tip. In one embodiment, theatraumatic tip 128 may have a distal opening (not shown) for accommodating a guide wire (not shown) that directs the guide wire away from the wall of the artery when thetherapeutic assembly 110 is in the pre-set deployed state 103 (FIG. 1C ). The curvature of thetip 128 can be varied depending upon the particular sizing/configuration of thetherapeutic assembly 110. In some embodiments, thetip 128 may also comprise one or more radiopaque markers (not shown) and/or one or more sensors (not shown). In one embodiment, thetip 128 can be part of (e.g., an extension of or integral with) theshaft 120. In one example, theflexible tip 128 can be a more flexible tapered portion (e.g., about 5 to about 7 mm) of thedistal end 126 of theshaft 120. Such an arrangement can be suitable for guidewire delivery of thetherapeutic assembly 110 to the target treatment site. In another embodiment, thetip 128 can be a separate component that may be affixed to thedistal end 126 of theshaft 120 via adhesive, crimping, over-molding, or other suitable techniques. Thetip 128 can be made from a polymer material (e.g., a polyether block amide copolymer sold under the trademark PEBAX, or a thermoplastic polyether urethane material sold under the trademarks ELASTHANE or PELLETHANE), or other suitable materials having the desired properties, including a selected durometer. In other embodiments, thetip 128 may be formed from different material(s) and/or have a different arrangement. -
FIG. 1C is a perspective view of thedistal portion 102 of thecatheter 100 ofFIG. 1B in the deployed state 103 (e.g., expanded configuration) in accordance with an embodiment of the present technology. In this embodiment, the control member 124 (FIG. 1A ) has a pre-set spiral/helical configuration that defines the deployedstate 103 of thetherapeutic assembly 110 such that the energy delivery portions 136 a-136 d of thethermocouple assembly 130 are offset from each other (e.g., both angularly and circumferentially offset relative to a longitudinal axis of the artery and/or angularly offset from each other along an axis of theshaft 120 when thethermocouple assembly 130 is in the deployed configuration). This configuration can provide stable apposition of the energy delivery portions 136 a-136 d with an inner surface of a wall of the artery (not shown) for treatment. As shown inFIG. 1C , the exposedregions 134 along thefirst wire 131 of thethermocouple assembly 130 are spaced apart from each other. However, because theinsulated regions 134 expose portions of a singlefirst wire 131, the energy delivery portions 136 a-136 d defined by the exposedregions 134 are in electrical communication with each other (e.g., commonly connected to an energy source). - Once deployed, the
therapeutic assembly 110 can deliver neuromodulating energy from a power source (not shown) and through the thermocouple assembly 130 (e.g., through the first wire 131) to the energy delivery portions 136 a-136 d. The purposeful application of energy (e.g., electrical energy such as RF energy and pulsed energy) to tissue at the treatment location within the artery (e.g., renal artery) can induce one or more desired effects at the treatment location, e.g., broadly across the treatment location or at localized regions of the treatment location. In one embodiment, an RF energy field can be delivered to the target nerves adjacent the wall of the artery via the energy delivery portions 136 a-136 d. In the illustrated embodiment, the energy delivery portions 136 a-136 are spaced apart both circumferentially and longitudinally along the wall of the interior lumen of the artery when thetherapeutic assembly 110 is in the deployedstate 103. Accordingly, application of energy via the energy delivery portions 136 a-136 d can result in a plurality of discontinuous lesions along the wall of the interior lumen of the artery. Temperature of the target tissue proximate thetherapeutic assembly 110 can be measured and monitored by thethermocouple assembly 130 at thejunction 133. - Referring to
FIGS. 1B and 1C together, and as described in more detail below with reference toFIG. 5 , thecatheter 100 may be configured for guidewire based delivery (e.g., over-the-wire (“OTW”) delivery, rapid exchange (“RX”) delivery) from an access site in which a guide wire (not shown) is initially inserted to a treatment site (e.g., within a renal artery), and thecatheter 100 is advanced over the guide wire. For example, the guide wire may be either inserted into or at least partially withdrawn from the shaft 120 (e.g., in thedistal portion 102 of the catheter 100) to transform thetherapeutic assembly 110 between the delivery state 101 (FIG. 1B ) and the deployed state 103 (FIG. 1C ). For example, a guide wire (not shown) extending through at least a portion of the length of the catheter 100 (e.g., through a lumen defined by the shaft 120) may be configured to straighten the pre-shaped spiral/helical control member 124 of thecatheter 100 during delivery, and the guide wire may be at least partially withdrawn or slideably moved relative to theshaft 120 to allow thetherapeutic assembly 110 to transform to the deployed state 103 (FIG. 1C ). - As best seen in
FIG. 1D , in its deployedstate 103, the spiral/helicaltherapeutic assembly 110 may have an outer diameter D of between about 4 mm and about 9 mm to accommodate, for example, blood vessel sizes having diameters in range of about 3 mm to about 8 mm. As noted above, the control member 124 (shown schematically as a broken line) is itself pre-set into a spiral/helical shape. The dimensions of the spiral/helical shape of thecontrol member 124 may be substantially the same as those of the spiral/helicaltherapeutic assembly 110. - In the embodiment illustrated in
FIGS. 1A-1C , thetherapeutic assembly 110 does not include dedicated electrodes separate from the exposedportions 134 of thefirst wire 131 of thethermocouple assembly 130, or any other conductors or bifilar wires that extend through the lumen or along the surface of theflexible tube 122 or elsewhere along theshaft 120. Instead, the embodiment illustrated inFIGS. 1A-1C is configured to deliver neuromodulating energy to target tissue via thethermocouple assembly 130. An advantage to this embodiment is that the additional manufacturing costs associated with adding separate electrodes and associated wiring of each individual electrode can be avoided while still delivering energy (e.g., RF energy) in suitable frequencies for desirably affecting the target tissue. In other embodiments not shown, however, one or more separate electrodes can be included in thetherapeutic assembly 110. For example, a separately wired electrode can be positioned at any location along the length L1 of thetherapeutic assembly 110 to deliver the same or a different form of energy as that of the energy delivery portions 136 of thethermocouple assembly 130. -
FIGS. 2A-2C illustrate assembly stages following steps in a method of forming a catheter apparatus 200 (“catheter 200”) having atherapeutic assembly 210 in adistal portion 202 of thecatheter 200 for therapeutically modulating sympathetic nerves in accordance with another embodiment of the present technology.FIG. 2D is a perspective view of thedistal portion 202 of thecatheter 200 ofFIG. 2C in a deployed state 203 (e.g., expanded configuration). Referring toFIGS. 2A-2D together, thecatheter 200 includes features generally similar to the features of thecatheter 100 described above with reference toFIGS. 1A-1C . For example, thedistal portion 202 of thecatheter 100 includes an elongatedtubular shaft 220, and includes atherapeutic assembly 210 having athermocouple assembly 230 positioned about theshaft 220. However, in the embodiment shown inFIGS. 2A-2D , thethermocouple assembly 230 includes ajunction 233 positioned proximal of adistal end 226 of theshaft 220 and includes a single exposed region 234 (e.g., an uninsulated region) of afirst wire 231 that extends distal to thejunction 233 and toward thedistal end 226. -
FIG. 2A is an enlarged cross-sectional side view of thetherapeutic assembly 210 in a partially assembled state illustrating a stage in the assembly method after thethermocouple assembly 230 has been aligned with and positioned alongside the shaft 220 (e.g., in adistal portion 202 of the catheter 200). Similar to the embodiment described above with respect toFIGS. 1A-1C , theshaft 220 can include aflexible tube 222 and a pre-shaped spiral/helical control member 224 within thetube 222.FIG. 2A also illustrates a step in the process of arranging thethermocouple assembly 230 after an insulating portion has been removed from along the conductivefirst wire 231 in theregion 234 between thejunction 233 and anend 239 of thefirst wire 231. Thethermocouple assembly 230 also includes an insulatedsecond wire 232 that terminates at thejunction 233. -
FIGS. 2B and 2C are enlarged, partial cross-sectional side views illustrating assembly stages following additional steps in the process for arranging thetherapeutic assembly 210 of thecatheter 200 shown inFIG. 2A . For example,FIG. 2B illustrates a partially assembled stage in the process after the exposedregion 234 of thefirst wire 231 has been helically positioned about theshaft 220. In this embodiment, theshaft 220 supports the exposedregion 234 about an outer circumference of the distal portion of theshaft 220 and along a length L2 of thetherapeutic assembly 210. As shown inFIG. 2B , the exposedregion 234 of thefirst wire 231 can be helically positioned (e.g., wound, wrapped, arranged, etc.) about the shaft 220 (e.g., in adistal portion 202 of the catheter 200) while thetherapeutic assembly 210 is in thedelivery state 201. In one example, thethermocouple assembly 230 can be positioned about theshaft 220 to create a helical shape. A variety of helical or non-helical arrangements, however, are suitable for positioning thethermocouple assembly 230 on or about theshaft 220. -
FIG. 2C illustrates a final assembly stage in the process after disposing one ormore sleeves 250 composed of insulative material about portions of thefirst wire 231 and the shaft 220 (e.g., in adistal portion 202 of the catheter 200). Thecatheter 200 is in a delivery state 201 (e.g., low profile or collapsed configuration) inFIG. 2C . The one ormore sleeves 250 can be placed along thetherapeutic assembly 210 in positions aligned with the exposedregion 234 of thefirst wire 231 to effectively disrupt the exposedregion 234. The portions of thefirst wire 231 that remain exposed (e.g., not covered by the sleeves 250) can define a plurality ofenergy delivery portions 236, which can deliver or otherwise transmit electrical energy (e.g., RF energy, pulsed energy, etc.) to target tissue in a manner similar to the energy delivery portions 136 described above with respect toFIGS. 1A-1C . In some embodiments, thesleeves 250 may be equally spaced apart along the length L2 of thetherapeutic assembly 210 to define the plurality ofenergy delivery portions 236. In some embodiments, the number ofenergy delivery portions 236 can be four; however, in other embodiments, the number and arrangement of theenergy delivery portions 236 may vary. - In one embodiment, the
sleeves 250 can be a flexible and insulative material such as polyethylene terephthalate (PET) heat shrink tubing or other shrink tubing materials known in the art. In other embodiments, thesleeves 250 can be composed of other polymer materials with or without additional insulative layers or materials. For example, thesleeves 250 may comprise one or more of the following materials: polyamide; polyimide; polyether block amide copolymer sold under the trademark PEBAX; polypropylene; aliphatic, polycarbonate-based thermoplastic polyurethane sold under the trademark CARBOTHANE; or a polyether ether ketone (PEEK) polymer that provides the desired material properties. In other embodiments, however, thesleeves 250 may be composed of other or additional suitable materials. - In some embodiments, the
sleeves 250 are portions of tubing suitable to place over thedistal end 226 of theshaft 220 and positioned at a further proximal site along thetherapeutic assembly 210. Thesleeves 250 can be heat shrunk around thefirst wire 231 and theshaft 220 using known processes in the art, such that the exposedregion 234 of the first wire 231 (e.g., the portion of thewire 231 after the insulating portion has been removed) is held in place (e.g., helically positioned about the shaft 220) and thesleeves 250 provide intermittently positionedinsulated regions 235 along thefirst wire 231 to define the plurality ofenergy delivery portions 236. In one embodiment, adhesive (not shown) can be placed between an inner surface of thesleeves 250 and the shaft 220 (e.g., the flexible tube 222) to prevent blood from collecting and/or clotting between thesleeves 250 and theshaft 220. In other embodiments, thesleeves 250 can include material that is wrapped about theshaft 220 and secured into position using known mechanical fastening components or adhesive. -
FIG. 2D is a perspective view of thedistal portion 202 of thecatheter 200 ofFIG. 2C in a deployed state 203 (e.g., expanded configuration) in accordance with an embodiment of the present technology. As previously described, the control member 224 (FIG. 2A ) has a pre-set spiral/helical configuration that can define the deployedstate 203 of thetherapeutic assembly 210 such that theenergy delivery portions 236 of thethermocouple assembly 230 are offset from each other (e.g., both angularly and circumferentially offset relative to a longitudinal axis of the artery and/or angularly offset from each other along an axis of theshaft 220 when thethermocouple assembly 210 is in the deployed configuration) and may be positioned in stable apposition with an inner surface of a wall of the artery (not shown) for treatment. Additionally, theenergy delivery portions 236 along thefirst wire 231 are defined by the spacing between thesleeves 250 and are spaced apart from each other when thetherapeutic assembly 210 is in the deployedstate 203. However, theenergy delivery portions 236 are commonly connected to each other. Once deployed, the therapeutic assembly 210 (like thetherapeutic assembly 110 shown inFIG. 1C ) can deliver neuromodulating energy from a power source (not shown) and through the thermocouple assembly 230 (e.g., through the first wire 231) to the target tissue via theenergy delivery portions 236. -
FIG. 3 illustrates adistal portion 302 of a catheter apparatus 300 (“catheter 300”) having atherapeutic assembly 310 or treatment section in a deployed state 303 (e.g., expanded configuration) in accordance with a further embodiment of the present technology.FIG. 3 is a perspective view of thedistal portion 302 that includes features generally similar to the features of thecatheters FIGS. 1A-2D . For example, thedistal portion 302 of thecatheter 100 includes an elongatedtubular shaft 320, and includes thetherapeutic assembly 310 having athermocouple assembly 330 positioned along theshaft 320. However, in the embodiment shown inFIG. 3 , thethermocouple assembly 330 is not helically positioned about theshaft 320; rather, thethermocouple assembly 330 is positioned longitudinally along the shaft 320 (e.g., in thedistal portion 302 of the shaft 320). The embodiment illustrated inFIG. 3 shows thethermocouple assembly 330 secured to theshaft 320 with one ormore sleeves 350, however, one of ordinary skill in the art will recognize that thethermocouple assembly 330 can be secured into position using other known mechanical fastening components (e.g., clips, collars, etc.) or adhesive. - The embodiment illustrated in
FIG. 3 includes thethermocouple assembly 330 having an arrangement similar to the thermocouple assembly arrangement shown inFIG. 1A . For example, thethermocouple assembly 330 includes a conductivefirst wire 331 and asecond wire 332 joined at ajunction 333 at least proximate to adistal end 326 of theshaft 320. As described above, the first andsecond wires insulative cover 337 over the wires, such as compacted mineral insulation and an outer sheath, or other appropriate conductive wire insulation known in the art. The conductivefirst wire 331 can relay and/or transmit an energy signal from an energy generating source (not shown), such as an RF energy generator located outside of the patient, and along a length of the conductivefirst wire 331 to thetherapeutic assembly 310. Similar to thethermocouple assembly 130 shown inFIG. 1A , thethermocouple assembly 330 includes a plurality of exposed regions 334 (e.g., uninsulated regions) andinsulated regions 335 along a portion of thefirst wire 331 to define a plurality ofenergy delivery portions 336 at the exposedregions 334. In this embodiment, the energy delivery portions 336 (e.g., the exposed regions 334) are along the same conductive path and, accordingly, commonly connected with each other. - In a pre-deployed configuration of the
therapeutic assembly 310, thesleeves 350 can be positioned along thetherapeutic assembly 310 to secure thethermocouple assembly 330 to theshaft 320. In this embodiment, thesleeves 350 can be similar to thesleeves 250 described above with respect toFIGS. 2C and 2D , or in another embodiment, thesleeves 350 may not include insulative properties, but serve to couple thethermocouple assembly 330 to the support structure 321. In some embodiments of devices described herein, a sleeve can perform both functions. In a delivery state, theshaft 320 has a longitudinal axis or orientation, and thethermocouple assembly 330 extends at least generally parallel to the longitudinal axis of theshaft 320. When deployed, thetherapeutic assembly 310 has a pre-set spiral/helical configuration that defines the deployedstate 303 of thetherapeutic assembly 310 such that theenergy delivery portions 336 of thethermocouple assembly 330 are both longitudinally offset (e.g., along the therapeutic assembly 310) and angularly or circumferentially offset (e.g., as defined by the spiral configuration of the shaft 320) from each other relative to a longitudinal axis of the artery. Accordingly, theenergy delivery portions 336 may be positioned in stable apposition with an inner surface of a wall of the artery (not shown) for treatment. - Features of the catheter device components described above and illustrated in
FIGS. 1A-3 can be modified to form additional embodiments configured in accordance with the present technology. For example, thecatheter 100 illustrated inFIGS. 1A-1C and other catheter apparatuses described above and illustrated inFIG. 2A without sleeves can include sleeves that provide additional coupling of the first and/or second thermocouple wires to the shaft and/or provide additional insulation in selected regions where the sleeves are positioned. Further modifications of thetherapeutic assembly 210 illustrated inFIG. 2B can include securing the exposedregion 234 of thefirst wire 231 with non-insulating mechanical components such that a continuous helical lesion (rather than discrete lesions formed in a helical pattern;FIGS. 2C and 2D ) can be achieved. Similarly, the catheters described above and illustrated inFIGS. 1A-3 can include one or more control members configured to receive one or more control wires (e.g., pull wires). A control wire can be used, for example, to control (e.g., deflect, angle, position, or steer) a distal portion of the shaft, a thermocouple assembly, or another catheter device component from outside the vasculature. - Features of the catheter device components described above also can be interchanged to form additional embodiments of the present technology. For example, while
FIG. 3 illustrates a therapeutic assembly having a non-helically positioned thermocouple assembly arrangement similar to the arrangement shown inFIG. 1A , another embodiment of a catheter in accordance with the present technology could include a therapeutic assembly having a non-helically positioned thermocouple assembly arrangement similar to the arrangement shown inFIG. 2A and including a plurality of insulative sleeves to define energy delivery portions. Additionally, the catheter apparatuses described above can also include additional thermocouple assemblies, electrode elements, wires, and energy delivery features positioned along the distal portion of the shaft. -
FIG. 4 is a partially schematic illustration of a neuromodulation system 400 (“system 400”) configured in accordance with an embodiment of the present technology. Thesystem 400 includes anintravascular catheter 401, which in various embodiments can be any of the catheters 100 (FIGS. 1A-1C ), 200 (FIGS. 2A-2D ), 300 (FIG. 3 ), or another of the catheters described above, operably coupled to an energy source or energy generator 402 (e.g., an RF energy generator). Thecatheter 401 can include anelongated shaft 404 having aproximal portion 406, ahandle 408 at a proximal region of theproximal portion 406, and adistal portion 410. Thecatheter 401 can further include a therapeutic assembly or treatment section 412 (shown schematically) at the distal portion 410 (e.g., attached to thedistal portion 410, defining a section of thedistal portion 410, etc.). As explained in further detail below, thetherapeutic assembly 412 can include asupport structure 414 and athermocouple assembly 416 accompanying thesupport structure 414. As discussed above with respect to the therapeutic assemblies of the catheter devices illustrated inFIGS. 1A-3 , thethermocouple assembly 416 can have an energy delivery wire (e.g., a first wire) having one or more exposed regions that define one or moreenergy delivery portions 418 along the length of thetherapeutic assembly 412 and which is configured to be delivered to a target blood vessel (e.g., an artery, vein or ostium) in a low-profile configuration. As mentioned previously, targeted blood vessels can include, for example, a renal artery, an ovarian artery, testicular artery, external iliac artery, internal iliac artery, internal pudendal artery, uterine artery, celiac artery, superior mesenteric artery, hepatic artery, splenic artery, gastric artery, pancreatic artery, and/or associated arterial branches. One of ordinary skill in the art will recognize that the therapeutic assemblies and catheter devices described herein may be suitable for other blood vessel targets and conditions. Examples of suitable therapeutic and catheter delivery methods for targeting a variety of blood vessels and for therapeutic treatment of a variety of conditions are described, for example, in U.S. patent application Ser. No. 13/691,594 filed Nov. 30, 2012; U.S. patent application Ser. No. 13/691,556 filed Nov. 30, 2012; International Publication No. PCT/US2013/029690, filed Mar. 7, 2013; International Publication No. PCT/US2013/029547, filed Mar. 7, 2013; International Publication No. PCT/US2013/029679, filed Mar. 7, 2013; and International Publication No. PCT/US2013/029574, filed Mar. 7, 2013 each of which are incorporated herein by reference in their entireties. - Upon delivery to the target treatment site within the target blood vessel (e.g., renal blood vessel), the
therapeutic assembly 412 is further configured to be deployed into an expanded state (e.g., a generally spiral/helical configuration, an expanded lasso or J-shaped configuration, etc.) for delivering energy at the treatment site and providing therapeutically-effective thermally-induced neuromodulation. Alternatively, the deployed state may be non-spiral provided that the deployed state provides adequate contact between energy delivery portions and the inner surface of the vessel wall. Thetherapeutic assembly 412 may be transformed between the delivery and deployed states using a variety of suitable mechanisms or techniques (e.g., self-expansion, remote actuation via an actuator, etc.). In a specific example, theneuromodulation assembly 412 may be placed or transformed into the deployed state or arrangement via remote actuation, e.g., via anactuator 409, such as a knob, pin, or lever carried by thehandle 408. In another example, following placement of the therapeutic assembly at the treatment site, advancement of a pre-shaped or expandable element or wire (e.g., a Nitinol wire) into a lumen of the shaft or flexible tube can cause the therapeutic assembly to assume its deployed state. - The proximal end of the
therapeutic assembly 412 is carried by or affixed to thedistal portion 410 of theelongated shaft 404. A distal end of thetherapeutic assembly 412 may terminate thecatheter 401 with, for example, anatraumatic tip 420. In some embodiments, the distal end of thetherapeutic assembly 412 may also be configured to engage another element of thesystem 400 orcatheter 401. For example, the distal end of thetherapeutic assembly 412 may define a passageway for receiving a guide wire (not shown) for delivery of the treatment device using OTW or rapid exchange (“RX”) techniques. Further details regarding such arrangements are described below. - The
catheter 401 can be electrically coupled to theenergy source 402 via acable 430, and the energy source 402 (e.g., an RF energy generator) can be configured to produce a selected modality and magnitude of energy for delivery to the treatment site via the thermocouple assembly'senergy delivery portions 418 along the first wire. As described in greater detail below, thermocouple wires (not shown) can extend along theelongated shaft 404 or through a lumen in theshaft 404 to thetherapeutic assembly 412 at thedistal portion 410 of theelongated shaft 404 and transmit the treatment energy to the energy delivery portions 418 (e.g., the exposed regions of the energy delivering thermocouple wire). Accordingly, eachenergy delivery portion 418 can receive and deliver energy supplied by the single energy delivery wire within thethermocouple assembly 416 instead of eachportion 418 having its own supply wire. Theenergy delivery portions 418 are positioned along the same electrical power wire or line, and accordingly, deliver power in a simultaneous fashion. - A
control mechanism 432, such as a foot pedal or handheld remote control device, may be connected to theenergy source 402 to allow the clinician to initiate, terminate and, optionally, adjust various operational characteristics of theenergy source 402, including, but not limited to, power delivery. The remote control device (not shown) can be positioned in a sterile field and operably coupled to the thermocouple assembly, and specifically to the energy delivering thermocouple wire having the exposed (e.g., uninsulated)energy delivery portions 418, and can be configured to allow the clinician to activate and deactivate the energy delivery to theenergy delivery portions 418. In other embodiments, the remote control device may be built into thehandle assembly 408. - The energy source or
energy generator 402 can be configured to deliver the treatment energy via anautomated control algorithm 434 and/or under the control of a clinician. For example, theenergy source 402 can include computing devices (e.g., personal computers, server computers, tablets, etc.) having processing circuitry (e.g., a microprocessor) that is configured to execute stored instructions relating to thecontrol algorithm 434. In addition, the processing circuitry may be configured to execute one or more evaluation/feedback algorithms 435, which can be communicated to the clinician. For example, theenergy source 402 can include a monitor or display 436 and/or associated features that are configured to provide visual, audio, or other indications of power levels, sensor data, and/or other feedback. Theenergy source 402 can also be configured to communicate the feedback and other information to another device, such as a monitor in a catheterization laboratory. - In some embodiments, the
system 400 may be configured to provide delivery of a monopolar electric field via theenergy delivery portions 418. In such embodiments, a neutral ordispersive electrode 438 may be electrically connected to theenergy generator 402 and attached to the exterior of the patient (as shown inFIG. 5 ). The individual energy delivery portions (e.g.,energy delivery portions FIGS. 1A-3 ) are connected to theenergy generator 402 and are sized and configured to contact an internal wall of the artery (e.g., the renal artery). In the illustrated embodiment, the energy delivery portions may be operated in a monopolar or unipolar mode. In this arrangement, a return path for the applied RF electric field is established, e.g., by the externaldispersive electrode 438, also called an indifferent electrode or neutral electrode. The monopolar application of RF electric field energy serves to ohmically or resistively heat tissue in the vicinity of the electrode. The application of the RF electrical field thermally injures tissue. The treatment objective is to thermally induce neuromodulation (e.g., necrosis, thermal alteration or ablation) in the targeted neural fibers. The thermal injury forms a lesion in the vessel wall. Alternatively, an RF electrical field may be delivered with an oscillating or pulsed intensity that does not thermally injure the tissue whereby neuromodulation in the targeted nerves is accomplished by electrical modification of the nerve signals. - The
system 400 can also include one or more additional sensors (not shown) located proximate to or within theenergy delivery portions 418. For example, thesystem 400 can include one or more other temperature sensors (e.g., one or more additional thermocouples, thermistors, etc.), impedance sensors, pressure sensors, optical sensors, flow sensors, and/or other suitable sensors connected to one or more supply wires (not shown) that transmit signals from the sensors and/or convey energy to thetherapeutic assembly 412. -
FIG. 5 (with additional reference toFIG. 4 ) illustrates modulating renal nerves with an embodiment of thesystem 400. Thecatheter 401 provides access to the renal plexus RP through an intravascular path P, such as a percutaneous access site in the femoral (illustrated), brachial, radial, or axillary artery to a targeted treatment site within a respective renal artery RA. As illustrated, a section of theproximal portion 406 of theshaft 404 is exposed externally of the patient. By manipulating theproximal portion 406 of theshaft 404 from outside the intravascular path P, the clinician may advance theshaft 404 through the sometimes tortuous intravascular path P and remotely manipulate thedistal portion 410 of theshaft 404. In the embodiment illustrated inFIG. 5 , thetherapeutic assembly 412 is delivered intravascularly to the treatment site using aguide wire 440 in an OTW technique. As noted previously, the distal end of thetherapeutic assembly 412 may define a lumen or passageway for receiving theguide wire 440 for delivery of thecatheter 401 using either OTW or RX techniques. At the treatment site, theguide wire 401 can be at least partially axially withdrawn or removed, and thetherapeutic assembly 412 can transform or otherwise be moved to a deployed arrangement for delivering energy at the treatment site as described above with respect toFIGS. 1A-3 . Theguide wire 440 may comprise any suitable medical guide wire sized to slideably fit within the lumen. In one particular embodiment, for example, theguide wire 440 may have a diameter of 0.356 mm (0.014 inch). In other embodiments, thetherapeutic assembly 412 may be delivered to the treatment site within a guide sheath (not shown) with or without using theguide wire 440. When thetherapeutic assembly 412 is at the target site, the guide sheath may be at least partially withdrawn or retracted and thetherapeutic assembly 412 can be transformed into the deployed arrangement. In still other embodiments, theshaft 404 may be steerable itself such that thetherapeutic assembly 412 may be delivered to the treatment site without the aid of theguide wire 440 and/or guide sheath. - Image guidance, e.g., computed tomography (CT), fluoroscopy, intravascular ultrasound (IVUS), optical coherence tomography (OCT), intracardiac echocardiography (ICE), or another suitable guidance modality, or combinations thereof, may be used to aid the clinician's positioning and manipulation of the
therapeutic assembly 412. For example, a fluoroscopy system (e.g., including a flat-panel detector, x-ray, or c-arm) can be rotated to accurately visualize and identify the target treatment site. In other embodiments, the treatment site can be determined using IVUS, OCT, and/or other suitable image mapping modalities that can correlate the target treatment site with an identifiable anatomical structure (e.g., a spinal feature) and/or a radiopaque ruler (e.g., positioned under or on the patient) before delivering thecatheter 401. Further, in some embodiments, image guidance components (e.g., IVUS, OCT) may be integrated with thecatheter 401 and/or run in parallel with thecatheter 401 to provide image guidance during positioning of thetherapeutic assembly 412. For example, image guidance components (e.g., IVUS or OCT) can be coupled to at least one of thetherapeutic assembly 412 to provide three-dimensional images of the vasculature proximate the target site to facilitate positioning or deploying thetherapeutic assembly 412 within the target renal blood vessel. - Referring to
FIGS. 4 and 5 together, the purposeful application of energy from the energy delivery portions 418 (e.g., the exposed regions of the energy delivering thermocouple wire) may be applied to target tissue to induce one or more desired neuromodulating effects on localized regions of the renal artery and adjacent regions of the renal plexus RP, which lay intimately within, adjacent to, or in close proximity to the adventitia of the renal artery RA. The purposeful application of the energy may achieve neuromodulation along all or at least a portion of the renal plexus RP. The neuromodulating effects are generally a function of, at least in part, power, time, contact between the energy delivery portions 418 (FIG. 4 ) and the vessel wall, and blood flow through the vessel. The neuromodulating effects may include denervation, thermal ablation, and/or non-ablative thermal alteration or damage (e.g., via sustained heating and/or resistive heating). Desired thermal heating effects may include raising the temperature of target neural fibers above a desired threshold to achieve non-ablative thermal alteration, or above a higher temperature to achieve ablative thermal alteration. For example, the target temperature may be above body temperature (e.g., approximately 37° C.) but less than about 45° C. for non-ablative thermal alteration, or the target temperature may be about 45° C. or higher for the ablative thermal alteration. Desired non-thermal neuromodulation effects may include altering the electrical signals transmitted in a nerve. - In operation (and with reference to
FIGS. 1A-5 ), after being positioned at a desired location within the renal artery RA of the patient, thetherapeutic assembly 412 may be transformed from its delivery state (e.g.,delivery state 101 shown inFIG. 1B ) to its deployed state (e.g., deployedstate 103 shown inFIG. 1C ). The transformation may be initiated using an arrangement of device components as described herein with respect to the particular embodiments and their various modes of deployment. In one embodiment, for example, thetherapeutic assembly 412 may be deployed by retracting theguide wire 440 until a distal tip of theguide wire 440 is generally aligned with thetip 420 of thecatheter 401. In some embodiments, theguide wire 440 may have a varying stiffness or flexibility along its length so as to provide increased flexibility distally. When the varyingflexible guide wire 440 is partially retracted as described above, the pre-set spiral shape of the control member 124 (FIG. 1A ) provides a shape-recovery force sufficient to overcome the straightening force provided by the distalmost portion of theguide wire 440 such that thetherapeutic assembly 412 can deploy into its spiral configuration. Further, because the flexible distal portion of theguide wire 440 remains within thetherapeutic assembly 412 in the deployed state 101 (e.g.,FIGS. 1B and 2C ), theguide wire 440 can impart additional structural integrity to the spiral-shaped portion during treatment. This feature is expected to help mitigate or reduce problems associated with keeping thetherapeutic assembly 412 in place during treatment (e.g., help with vasoconstriction). - In another embodiment, the
guide wire 440 may have a stiffness profile that permits the distal portion of theguide wire 440 to remain extended from an opening (not shown) in thetip 420 while still permitting thetherapeutic assembly 412 to transform to its deployed state (e.g., deployedstate 103 shown inFIG. 1C ). In still other embodiments, theguide wire 440 may be withdrawn completely from the therapeutic assembly 412 (e.g., a distalmost end portion of theguide wire 440 is proximal of the therapeutic assembly 412) to permit the transformation, while a distalmost portion of theguide wire 440 remains within theshaft 404. In yet another embodiment, theguide wire 440 may be withdrawn completely from theshaft 404. In any of the foregoing examples, the clinician can withdraw theguide wire 440 sufficiently to observe transformation of thetherapeutic assembly 412 to the deployed configuration and/or until an X-ray image shows that the distal tip of theguide wire 440 is at a desired location relative to the therapeutic assembly 412 (e.g., generally aligned with thetip 420, completely withdrawn from thetherapeutic assembly 412, etc.). In some embodiments, the extent of withdrawal for theguide wire 440 can be based, at least in part, on the clinician's judgment with respect to the selected guide wire and the extent of withdrawal necessary to achieve deployment. - After treatment, the
therapeutic assembly 412 may be transformed back to the low-profile delivery configuration by axially advancing theguide wire 440 relative to thetherapeutic assembly 412. In one embodiment, for example, theguide wire 440 may be advanced until the distal tip of theguide wire 440 is generally aligned with thetip 420, and thecatheter 401 can then be pulled back over thestationary guide wire 440. In other embodiments, however, the distalmost portion of theguide wire 440 may be advanced to a different location relative to thetherapeutic assembly 412 to achieve transformation of thetherapeutic assembly 412 back to a low-profile arrangement. - Neuromodulation is the partial or complete incapacitation or other effective disruption of nerves innervating, for example, an organ. As an example, renal neuromodulation is the partial or complete incapacitation or other effective disruption of nerves innervating the kidneys. In particular, renal neuromodulation comprises inhibiting, reducing, and/or blocking neural communication along neural fibers (i.e., efferent and/or afferent nerve fibers) innervating the kidneys. Such incapacitation can be long-term (e.g., permanent or for periods of months, years, or decades) or short-term (e.g., for periods of minutes, hours, days, or weeks). Renal neuromodulation is expected to efficaciously treat several clinical conditions characterized by increased overall sympathetic activity, and in particular conditions associated with central sympathetic over-stimulation such as hypertension, heart failure, acute myocardial infarction, metabolic syndrome, insulin resistance, diabetes, left ventricular hypertrophy, chronic and end stage renal disease, inappropriate fluid retention in heart failure, cardio-renal syndrome, osteoporosis, and sudden death. The reduction of afferent neural signals contributes to the systemic reduction of sympathetic tone/drive, and renal neuromodulation is expected to be useful in treating several conditions associated with systemic sympathetic over activity or hyperactivity. Renal neuromodulation can potentially benefit a variety of organs and bodily structures innervated by sympathetic nerves.
- Various techniques can be used to partially or completely incapacitate neural pathways, such as those innervating the kidney. The purposeful application of energy (e.g., electrical energy, thermal energy) to tissue by energy delivery element(s) or components such as those described in conjunction with the catheter devices above, can induce one or more desired thermal heating effects on localized regions of the renal artery and adjacent regions of the renal plexus, which lay intimately within or adjacent to the adventitia of the renal artery. The purposeful application of the thermal heating effects can achieve neuromodulation along all or a portion of the renal plexus.
- The thermal heating effects can include both thermal ablation and non-ablative thermal alteration or damage (e.g., via sustained heating and/or resistive heating). Desired thermal heating effects may include raising the temperature of target neural fibers above a desired threshold to achieve non-ablative thermal alteration, or above a higher temperature to achieve ablative thermal alteration. For example, the target temperature can be above body temperature (e.g., approximately 37° C.) but less than about 45° C. for non-ablative thermal alteration, or the target temperature can be about 45° C. or higher for the ablative thermal alteration.
- More specifically, exposure to thermal energy (heat) in excess of a body temperature of about 37° C., but below a temperature of about 45° C., may induce thermal alteration via moderate heating of the target neural fibers or of vascular structures that perfuse the target fibers. In cases where vascular structures are affected, the target neural fibers are denied perfusion resulting in necrosis of the neural tissue. For example, this may induce non-ablative thermal alteration in the fibers or structures. Exposure to heat above a temperature of about 45° C., or above about 60° C., may induce thermal alteration via substantial heating of the fibers or structures. For example, such higher temperatures may thermally ablate the target neural fibers or the vascular structures. In some patients, it may be desirable to achieve temperatures that thermally ablate the target neural fibers or the vascular structures, but that are less than about 90° C., or less than about 85° C., or less than about 80° C., and/or less than about 75° C. Regardless of the type of heat exposure utilized to induce the thermal neuromodulation, a reduction in renal sympathetic nerve activity (RSNA) is expected.
- The following examples are illustrative of several embodiments of the present technology:
- 1. A method of manufacturing a medical device for neuromodulation (e.g., neuromodulation of renal nerves), the method comprising:
-
- positioning a thermocouple assembly along a distal portion of a catheter, wherein the thermocouple assembly comprises a first wire and a second wire composed of dissimilar metals, and wherein the thermocouple assembly comprises a thermocouple junction at least proximate the distal portion;
- wherein the first wire has a plurality of exposed and insulated regions along a portion of the first wire proximate the distal portion, and the second wire of the thermocouple assembly remains insulated; and
- wherein the distal portion of the catheter includes an elongated tubular shaft configured to transform between a delivery configuration and a deployed configuration at a target treatment site within a blood vessel of a human patient, and wherein, in the deployed configuration, the exposed regions of the first wire define a plurality of energy delivery portions positioned to deliver electrical energy (e.g., RF energy, pulsed energy) to target tissue adjacent a wall of the blood vessel.
- 2. The method of example 1 wherein disposing a thermocouple assembly along a distal portion of a catheter comprises helically positioning the thermocouple assembly about the shaft.
- 3. The method of example 1 or example 2 wherein the shaft comprises a tubular structure having a lumen therethrough and a self-expanding, shape-memory material disposed within the lumen.
- 4. The method of any one of examples 1-3 wherein the shaft comprises a tubular structure having a lumen therethrough and is composed of a Nitinol multifilar stranded wire.
- 5. The method of any one of examples 1-4 wherein the method further comprises coating the exposed regions of the first wire with a biocompatible conductive material.
- 6. The method of any one of examples 1-5 wherein the exposed regions along the first wire of the thermocouple assembly are in electrical communication with each other.
- 7. The method of any one of examples 1-6, further comprising selectively removing portions of the first wire of the thermocouple assembly to define a plurality of exposed and insulated regions.
- 8. The method of example 7 wherein selectively removing portions of the first wire of the thermocouple assembly comprises forming four exposed regions along the first wire.
- 9. The method of any one of examples 1-8 wherein, in the deployed configuration, the shaft carrying the thermocouple assembly comprises a radially expanded, generally spiral shape configured to contact the wall of the blood vessel and to allow blood to flow through the vessel.
- 10. The method of any one of examples 1-9, further comprising disposing one or more sleeves composed of insulative material about the thermocouple assembly and the shaft.
- 11. The method of example 10 wherein the sleeves comprise polyethylene terephthalate (PET) heat shrink tubing.
- 12. The method of any one of examples 1-11 wherein the first wire is composed of copper and the second wire is composed of constantan.
- 13. The method of any one of examples 1-11 wherein the first wire is composed of silver coated nickel and the second wire is composed of constantan.
- 14. The method of any one of examples 1-11 wherein the first wire is composed of nickel and the second wire is composed of constantan.
- 15. The method of any one of examples 1-11 wherein the first wire is composed of silver and the second wire is composed of constantan.
- 16. A catheter apparatus, comprising:
-
- an elongated tubular shaft in a distal portion of the catheter apparatus, the shaft having a pre-formed spiral shape; and
- a therapeutic assembly disposed at the distal portion of the catheter apparatus and adapted to be located at a target location within an artery (e.g., a renal artery) of a human patient, the therapeutic assembly comprising a thermocouple assembly helically wrapped about the shaft, wherein the thermocouple assembly comprises a thermocouple junction at least proximate a distal portion of the shaft, and a first wire and a second wire composed of dissimilar metals, wherein the first wire comprises a plurality of exposed and insulated regions along the shaft, and further wherein the second wire is insulated along the shaft,
- wherein the elongated tubular shaft and the therapeutic assembly together define therethrough a guide wire lumen configured to slideably receive a medical guide wire,
- wherein axial movement of the guide wire relative to the therapeutic assembly transforms the shaft between (a) a low-profile delivery configuration and (b) a deployed configuration tending to assume the pre-formed spiral shape of the shaft,
- wherein, in the deployed configuration, the exposed regions of the first wire define a plurality of energy delivery portions positioned to deliver electrical energy (e.g., RF energy, pulsed energy) to target tissue adjacent a wall of the artery.
- 17. The catheter apparatus of example 16 wherein, in the deployed configuration, the energy delivery portions of the first wire are spaced apart from each other along a longitudinal axis of the artery and are configured to maintain apposition with a wall of the artery.
- 18. The catheter apparatus of example 16 or example 17 wherein the shaft comprises a tubular member having a lumen therethrough and is composed of a Nitinol multifilar stranded wire.
- 19. The catheter apparatus of any one of examples 16-18 wherein the exposed regions along the first wire of the thermocouple assembly do not contact each other in the delivery or deployed configurations.
- 20. The catheter apparatus of any one of examples 16-19 wherein the individual energy delivery portions are in electrical communication with each other.
- 21. The catheter apparatus of any one of examples 16-20 wherein the first wire of the thermocouple assembly comprises four energy delivery portions.
- 22. The catheter apparatus of any one of examples 16-21 wherein the therapeutic assembly does not include any electrodes.
- 23. The catheter apparatus of any one of examples 16-22 wherein the energy delivery portions are configured to deliver a thermal radiofrequency field to target nerves adjacent the wall of the artery.
- 24. A catheter system, comprising:
-
- an electric field generator configured to deliver radiofrequency (RF) energy to target tissue of a human patient;
- a catheter having a distal portion configured for placement within a blood vessel of the patient;
- a treatment assembly at the distal portion of the catheter, wherein the treatment assembly is selectively transformable between a low-profile delivery configuration and a deployed configuration sized to fit within the blood vessel;
- a thermocouple arranged about the distal portion of the catheter and electrically connectable to the electric field generator, wherein the thermocouple comprises—
- a first conductive wire having a plurality of predefined uninsulated regions at the distal portion of the catheter that define RF energy delivery portions positioned to deliver RF energy to the target tissue when the treatment assembly is in the deployed configuration;
- a second insulated wire adjacent to the first wire and composed of a different material than the first wire; and
- a thermocouple junction at least proximate the distal portion of the catheter.
- The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments.
- From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.
- Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
Claims (24)
1. A method of manufacturing a medical device for neuromodulation, the method comprising:
positioning a thermocouple assembly along a distal portion of a catheter, wherein the thermocouple assembly comprises a first wire and a second wire composed of dissimilar metals, and wherein the thermocouple assembly comprises a thermocouple junction at least proximate the distal portion;
wherein the first wire has a plurality of exposed and insulated regions along a portion of the first wire proximate the distal portion, and the second wire of the thermocouple assembly remains insulated; and
wherein the distal portion of the catheter includes an elongated tubular shaft configured to transform between a delivery configuration and a deployed configuration at a target treatment site within a blood vessel of a human patient, and wherein, in the deployed configuration, the exposed regions of the first wire define a plurality of energy delivery portions positioned to deliver energy to target tissue adjacent a wall of the blood vessel.
2. The method of claim 1 wherein disposing a thermocouple assembly along a distal portion of a catheter comprises helically positioning the thermocouple assembly about the shaft.
3. The method of claim 1 wherein the shaft comprises a tubular structure having a lumen therethrough and a self-expanding, shape-memory material disposed within the lumen.
4. The method of claim 1 wherein the shaft comprises a tubular structure having a lumen therethrough and is composed of a Nitinol multifilar stranded wire.
5. The method of claim 1 wherein the method further comprises coating the exposed regions of the first wire with a biocompatible conductive material.
6. The method of claim 1 wherein the exposed regions along the first wire of the thermocouple assembly are in electrical communication with each other.
7. The method of claim 1 , further comprising selectively removing portions of the first wire of the thermocouple assembly to define a plurality of exposed and insulated regions.
8. The method of claim 7 wherein selectively removing portions of the first wire of the thermocouple assembly comprises forming four exposed regions along the first wire.
9. The method of claim 1 wherein, in the deployed configuration, the shaft carrying the thermocouple assembly comprises a radially expanded, generally spiral shape configured to contact the wall of the blood vessel and to allow blood to flow through the vessel.
10. The method of claim 1 , further comprising disposing one or more sleeves composed of insulative material about the thermocouple assembly and the shaft.
11. The method of claim 10 wherein the sleeves comprise polyethylene terephthalate (PET) heat shrink tubing.
12. The method of claim 1 wherein the first wire is composed of copper and the second wire is composed of constantan.
13. The method of claim 1 wherein the first wire is composed of silver coated nickel and the second wire is composed of constantan.
14. The method of claim 1 wherein the first wire is composed of nickel and the second wire is composed of constantan.
15. The method of claim 1 wherein the first wire is composed of silver and the second wire is composed of constantan.
16. A catheter apparatus, comprising:
an elongated tubular shaft in a distal portion of the catheter apparatus, the shaft having a pre-formed spiral shape; and
a therapeutic assembly disposed at the distal portion of the catheter apparatus and adapted to be located at a target location within an artery of a human patient, the therapeutic assembly comprising a thermocouple assembly helically wrapped about the shaft, wherein the thermocouple assembly comprises a thermocouple junction at least proximate a distal portion of the shaft, and a first wire and a second wire composed of dissimilar metals, wherein the first wire comprises a plurality of exposed and insulated regions along the shaft, and further wherein the second wire is insulated along the shaft,
wherein the elongated tubular shaft and the therapeutic assembly together define therethrough a guide wire lumen configured to slideably receive a medical guide wire,
wherein axial movement of the guide wire relative to the therapeutic assembly transforms the shaft between (a) a low-profile delivery configuration and (b) a deployed configuration tending to assume the pre-formed spiral shape of the shaft,
wherein, in the deployed configuration, the exposed regions of the first wire define a plurality of energy delivery portions positioned to deliver energy to target tissue adjacent a wall of the artery.
17. The catheter apparatus of claim 16 wherein, in the deployed configuration, the energy delivery portions of the first wire are spaced apart from each other along a longitudinal axis of the artery and are configured to maintain apposition with a wall of the artery.
18. The catheter apparatus of claim 16 wherein the shaft comprises a tubular member having a lumen therethrough and is composed of a Nitinol multifilar stranded wire.
19. The catheter apparatus of claim 16 wherein the exposed regions along the first wire of the thermocouple assembly do not contact each other in the delivery or deployed configurations.
20. The catheter apparatus of claim 16 wherein the individual energy delivery portions are in electrical communication with each other.
21. The catheter apparatus of claim 16 wherein the first wire of the thermocouple assembly comprises four energy delivery portions.
22. The catheter apparatus of claim 16 wherein the therapeutic assembly does not include any electrodes.
23. The catheter apparatus of claim 16 wherein the energy delivery portions are configured to deliver a thermal radiofrequency field to target nerves adjacent the wall of the artery.
24. A catheter system, comprising:
an electric field generator configured to deliver radiofrequency (RF) energy to target tissue of a human patient;
a catheter having a distal portion configured for placement within a blood vessel of the patient;
a treatment assembly at the distal portion of the catheter, wherein the treatment assembly is selectively transformable between a low-profile delivery configuration and a deployed configuration sized to fit within the blood vessel;
a thermocouple arranged about the distal portion of the catheter and electrically connectable to the electric field generator, wherein the thermocouple comprises—
a first conductive wire having a plurality of predefined uninsulated regions at the distal portion of the catheter that define RF energy delivery portions positioned to deliver RF energy to the target tissue when the treatment assembly is in the deployed configuration;
a second insulated wire adjacent to the first wire and composed of a different material than the first wire; and
a thermocouple junction at least proximate the distal portion of the catheter.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/021,838 US20150073515A1 (en) | 2013-09-09 | 2013-09-09 | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
PCT/US2014/054654 WO2015035350A1 (en) | 2013-09-09 | 2014-09-09 | Neuromodulation catheter devices and systems having energy delivering thermocouple assemblies and associated methods |
EP14772511.3A EP3043857B1 (en) | 2013-09-09 | 2014-09-09 | Neuromodulation catheter devices and systems having energy delivering thermocouple assemblies and associated methods |
CN201480049431.5A CN105555348B (en) | 2013-09-09 | 2014-09-09 | With the nerve modulation conduit device of energy delivery thermocouple assembly and system and associated method |
US16/290,565 US11213678B2 (en) | 2013-09-09 | 2019-03-01 | Method of manufacturing a medical device for neuromodulation |
US17/546,600 US20220096826A1 (en) | 2013-09-09 | 2021-12-09 | Neuromodulation catheter devices and systems having energy delivering thermocouple assemblies and associated methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/021,838 US20150073515A1 (en) | 2013-09-09 | 2013-09-09 | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/290,565 Division US11213678B2 (en) | 2013-09-09 | 2019-03-01 | Method of manufacturing a medical device for neuromodulation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150073515A1 true US20150073515A1 (en) | 2015-03-12 |
Family
ID=51619291
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/021,838 Abandoned US20150073515A1 (en) | 2013-09-09 | 2013-09-09 | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
US16/290,565 Active 2034-03-18 US11213678B2 (en) | 2013-09-09 | 2019-03-01 | Method of manufacturing a medical device for neuromodulation |
US17/546,600 Pending US20220096826A1 (en) | 2013-09-09 | 2021-12-09 | Neuromodulation catheter devices and systems having energy delivering thermocouple assemblies and associated methods |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/290,565 Active 2034-03-18 US11213678B2 (en) | 2013-09-09 | 2019-03-01 | Method of manufacturing a medical device for neuromodulation |
US17/546,600 Pending US20220096826A1 (en) | 2013-09-09 | 2021-12-09 | Neuromodulation catheter devices and systems having energy delivering thermocouple assemblies and associated methods |
Country Status (4)
Country | Link |
---|---|
US (3) | US20150073515A1 (en) |
EP (1) | EP3043857B1 (en) |
CN (1) | CN105555348B (en) |
WO (1) | WO2015035350A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
EP3222237A1 (en) * | 2016-03-24 | 2017-09-27 | Cook Medical Technologies LLC | Medical device |
US9775627B2 (en) | 2012-11-05 | 2017-10-03 | Relievant Medsystems, Inc. | Systems and methods for creating curved paths through bone and modulating nerves within the bone |
US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
US10111704B2 (en) | 2002-09-30 | 2018-10-30 | Relievant Medsystems, Inc. | Intraosseous nerve treatment |
US10265099B2 (en) | 2008-09-26 | 2019-04-23 | Relievant Medsystems, Inc. | Systems for accessing nerves within bone |
CN109907822A (en) * | 2019-04-09 | 2019-06-21 | 北京博海康源医疗器械有限公司 | A kind of RF ablation closure microtubular |
US10390877B2 (en) | 2011-12-30 | 2019-08-27 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
US10463423B2 (en) | 2003-03-28 | 2019-11-05 | Relievant Medsystems, Inc. | Thermal denervation devices and methods |
US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
USRE48460E1 (en) | 2002-09-30 | 2021-03-09 | Relievant Medsystems, Inc. | Method of treating an intraosseous nerve |
US11007010B2 (en) | 2019-09-12 | 2021-05-18 | Relevant Medsysterns, Inc. | Curved bone access systems |
CN113693716A (en) * | 2020-05-22 | 2021-11-26 | Tau-Pnu医疗有限公司 | Radiofrequency electrode ablation catheter with cooling function for interventricular therapy |
CN113693717A (en) * | 2021-08-30 | 2021-11-26 | 上海安通医疗科技有限公司 | Radio frequency ablation catheter for radial artery access |
US20220061915A1 (en) * | 2020-05-22 | 2022-03-03 | Tau-Pnu Medical Co., Ltd. | Rf ablation catheter for septal reduction therapy having cooling effect |
US20220218412A1 (en) * | 2019-05-07 | 2022-07-14 | CRC EP, Inc. | Mapping and ablation catheter with multiple loop segments |
US11454627B2 (en) * | 2017-01-26 | 2022-09-27 | Katholieke Universiteit Leuven | Sensor |
CN116059533A (en) * | 2023-02-20 | 2023-05-05 | 湖南安泰康成生物科技有限公司 | Active heat dissipation electrode slice and electrode device |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113520582B (en) * | 2018-12-12 | 2022-10-04 | 上海魅丽纬叶医疗科技有限公司 | Radiofrequency ablation catheter with shape-stabilized design and mesh tubular support structure and manufacturing process thereof |
CN114098922A (en) * | 2021-11-18 | 2022-03-01 | 南京脉创医疗科技有限公司 | Renal artery ablation guiding catheter through radial artery |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322559B1 (en) * | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US20050267465A1 (en) * | 2004-05-26 | 2005-12-01 | Baylis Medical Company Inc. | Multifunctional electrosurgical apparatus |
US20130304062A1 (en) * | 2012-05-14 | 2013-11-14 | Biosense Webster (Irael), Ltd. | Catheter with helical end section for vessel ablation |
US20140276747A1 (en) * | 2013-03-15 | 2014-09-18 | Abbott Cardiovascular Systems Inc. | System and method for denervation |
US20140276748A1 (en) * | 2013-03-15 | 2014-09-18 | Medtronic Ardian Luxembourg S.a.r.I. | Helical Push Wire Electrode |
Family Cites Families (548)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1456509A (en) | 1973-02-20 | 1976-11-24 | Dow Corning Ltd | Bonding silicone rubber to wood and masonry |
US4154246A (en) | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4169464A (en) | 1977-12-16 | 1979-10-02 | Cordis Corporation | Catheter for selective catheterization of aortic branches |
JPS55134141A (en) | 1979-04-02 | 1980-10-18 | Mitsubishi Chem Ind Ltd | Rare earth element ion separating method |
US4419819A (en) | 1982-01-29 | 1983-12-13 | Medtronic, Inc. | Method of making biomedical lead with lobed lead anchor |
EP0132344A3 (en) | 1983-07-20 | 1986-01-22 | Purdue Research Foundation | Improved catheter based cardiac output sensor |
US4618600A (en) | 1984-04-19 | 1986-10-21 | Biotechnology Research Associates, J.V. | Novel polypeptide diuretic/vasodilators |
US4602624A (en) | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
US4649936A (en) | 1984-10-11 | 1987-03-17 | Case Western Reserve University | Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking |
JPS61116595A (en) | 1984-11-12 | 1986-06-04 | Riso Kagaku Corp | Thermal stencil paper |
JPS61151245A (en) | 1984-12-25 | 1986-07-09 | Sumitomo Electric Ind Ltd | Method for treating surface of porous thin membrane material |
US4706671A (en) | 1985-05-02 | 1987-11-17 | Weinrib Harry P | Catheter with coiled tip |
US4660571A (en) | 1985-07-18 | 1987-04-28 | Cordis Corporation | Percutaneous lead having radially adjustable electrode |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US4796643A (en) | 1986-09-30 | 1989-01-10 | Telectronics N.V. | Medical electrode leads |
US5365926A (en) | 1986-11-14 | 1994-11-22 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
US4834724A (en) | 1987-04-06 | 1989-05-30 | Geiss Alan C | Device for aspirating fluids from a body cavity or hollow organ |
US4781682A (en) | 1987-08-13 | 1988-11-01 | Patel Piyush V | Catheter having support flaps and method of inserting catheter |
US5154705A (en) | 1987-09-30 | 1992-10-13 | Lake Region Manufacturing Co., Inc. | Hollow lumen cable apparatus |
US4819661A (en) | 1987-10-26 | 1989-04-11 | Cardiac Pacemakers, Inc. | Positive fixation cardiac electrode with drug elution capabilities |
US4860769A (en) | 1987-11-12 | 1989-08-29 | Thomas J. Fogarty | Implantable defibrillation electrode |
US4957118A (en) | 1988-01-15 | 1990-09-18 | Jay Erlebacher | Electrode lead |
US4890623A (en) | 1988-03-14 | 1990-01-02 | C. R. Bard, Inc. | Biopotential sensing device and method for making |
EP0377749B1 (en) | 1988-06-06 | 1994-08-31 | Sumitomo Electric Industries, Ltd. | Catheter |
US4921484A (en) | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
US5249585A (en) | 1988-07-28 | 1993-10-05 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US4920979A (en) | 1988-10-12 | 1990-05-01 | Huntington Medical Research Institute | Bidirectional helical electrode for nerve stimulation |
US4995868A (en) | 1988-10-12 | 1991-02-26 | Bard Limited | Catheter |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US4966597A (en) | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
WO1990007303A1 (en) | 1989-01-06 | 1990-07-12 | Angioplasty Systems, Inc. | Electrosurgical catheter for resolving atherosclerotic plaque |
US5779698A (en) | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US4976711A (en) | 1989-04-13 | 1990-12-11 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5156610A (en) | 1989-08-18 | 1992-10-20 | Evi Corporation | Catheter atherotome |
US5282484A (en) | 1989-08-18 | 1994-02-01 | Endovascular Instruments, Inc. | Method for performing a partial atherectomy |
US5071424A (en) | 1989-08-18 | 1991-12-10 | Evi Corporation | Catheter atherotome |
US5211651A (en) | 1989-08-18 | 1993-05-18 | Evi Corporation | Catheter atherotome |
US5002067A (en) | 1989-08-23 | 1991-03-26 | Medtronic, Inc. | Medical electrical lead employing improved penetrating electrode |
US5016808A (en) | 1989-09-14 | 1991-05-21 | Cardiac Pacemakers, Inc. | Implantable tapered spiral endocardial lead for use in internal defibrillation |
US5133365A (en) | 1989-09-14 | 1992-07-28 | Cardiac Pacemakers, Inc. | Implantable tapered spiral endocardial lead for use in internal defibrillation |
US5209723A (en) | 1990-01-08 | 1993-05-11 | The Curators Of The University Of Missouri | Multiple lumen catheter for hemodialysis |
US5158564A (en) | 1990-02-14 | 1992-10-27 | Angiomed Ag | Atherectomy apparatus |
US5052998A (en) | 1990-04-04 | 1991-10-01 | Zimmon David S | Indwelling stent and method of use |
US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5054501A (en) | 1990-05-16 | 1991-10-08 | Brigham & Women's Hospital | Steerable guide wire for cannulation of tubular or vascular organs |
US5188602A (en) | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5163928A (en) | 1991-01-07 | 1992-11-17 | Franklin Electronic Publishers, Incorporated | Self-centering catheter |
US5345936A (en) | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
US5228442A (en) | 1991-02-15 | 1993-07-20 | Cardiac Pathways Corporation | Method for mapping, ablation, and stimulation using an endocardial catheter |
US5156151A (en) | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
US5188619A (en) | 1991-04-24 | 1993-02-23 | Gene E. Myers Enterprises, Inc. | Internal thoractic artery catheter |
DE4113703C2 (en) | 1991-04-26 | 1995-05-04 | Thomas Osypka | Guide catheter with pre-bent end area |
US5330496A (en) | 1991-05-06 | 1994-07-19 | Alferness Clifton A | Vascular catheter assembly for tissue penetration and for cardiac stimulation and methods thereof |
WO1992020291A1 (en) | 1991-05-24 | 1992-11-26 | Applied Medical Resources, Inc. | Articulating tissue cutter assembly |
US5628775A (en) | 1991-11-08 | 1997-05-13 | Ep Technologies, Inc. | Flexible bond for sleeves enclosing a bendable electrode tip assembly |
ATE241938T1 (en) | 1991-11-08 | 2003-06-15 | Boston Scient Ltd | ABLATION ELECTRODE WITH INSULATED TEMPERATURE MEASUREMENT ELEMENT |
US5358514A (en) | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5683366A (en) | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5354297A (en) | 1992-02-14 | 1994-10-11 | Boaz Avitall | Biplanar deflectable catheter for arrhythmogenic tissue ablation |
US5327905A (en) | 1992-02-14 | 1994-07-12 | Boaz Avitall | Biplanar deflectable catheter for arrhythmogenic tissue ablation |
US5263493A (en) | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
US5300099A (en) | 1992-03-06 | 1994-04-05 | Urologix, Inc. | Gamma matched, helical dipole microwave antenna |
US5239999A (en) | 1992-03-27 | 1993-08-31 | Cardiac Pathways Corporation | Helical endocardial catheter probe |
WO1993020878A1 (en) | 1992-04-10 | 1993-10-28 | Cardiorhythm | Shapable handle for steerable electrode catheter |
US5318525A (en) | 1992-04-10 | 1994-06-07 | Medtronic Cardiorhythm | Steerable electrode catheter |
US5345031A (en) | 1992-04-16 | 1994-09-06 | The Trustees Of Princeton University | Reduction of aromatic halide content |
US5300068A (en) | 1992-04-21 | 1994-04-05 | St. Jude Medical, Inc. | Electrosurgical apparatus |
US5263492A (en) | 1992-04-30 | 1993-11-23 | Guy Voyce | Recording goniometer |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
DE69328096T2 (en) | 1992-06-26 | 2000-09-14 | Schneider Usa Inc | CATHETER WITH EXTENDABLE MACHINE WIRE TIP |
US5772590A (en) | 1992-06-30 | 1998-06-30 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire |
US5484400A (en) | 1992-08-12 | 1996-01-16 | Vidamed, Inc. | Dual channel RF delivery system |
US5542916A (en) | 1992-08-12 | 1996-08-06 | Vidamed, Inc. | Dual-channel RF power delivery system |
US6623516B2 (en) | 1992-08-13 | 2003-09-23 | Mark A. Saab | Method for changing the temperature of a selected body region |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
US5634899A (en) | 1993-08-20 | 1997-06-03 | Cortrak Medical, Inc. | Simultaneous cardiac pacing and local drug delivery method |
CA2109980A1 (en) | 1992-12-01 | 1994-06-02 | Mir A. Imran | Steerable catheter with adjustable bend location and/or radius and method |
SE9203733D0 (en) | 1992-12-11 | 1992-12-11 | Siemens Elema Ab | defibrillation |
US5256141A (en) | 1992-12-22 | 1993-10-26 | Nelson Gencheff | Biological material deployment method and apparatus |
US5387233A (en) | 1993-01-11 | 1995-02-07 | Incontrol, Inc. | Intravenous cardiac lead with improved fixation and method |
IT1266217B1 (en) | 1993-01-18 | 1996-12-27 | Xtrode Srl | ELECTROCATHETER FOR MAPPING AND INTERVENTION ON HEART CAVITIES. |
US5636634A (en) | 1993-03-16 | 1997-06-10 | Ep Technologies, Inc. | Systems using guide sheaths for introducing, deploying, and stabilizing cardiac mapping and ablation probes |
US5476495A (en) | 1993-03-16 | 1995-12-19 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
EP0673225A4 (en) | 1993-03-16 | 1996-01-24 | Ep Technologies | Cardiac mapping and ablation systems. |
JP3345786B2 (en) | 1993-03-17 | 2002-11-18 | ジャパンゴアテックス株式会社 | Flexible tube and method of manufacturing the same |
US5383856A (en) | 1993-03-19 | 1995-01-24 | Bersin; Robert M. | Helical spiral balloon catheter |
US5523092A (en) | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
US5716410A (en) | 1993-04-30 | 1998-02-10 | Scimed Life Systems, Inc. | Temporary stent and method of use |
US5693082A (en) | 1993-05-14 | 1997-12-02 | Fidus Medical Technology Corporation | Tunable microwave ablation catheter system and method |
US5860974A (en) | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
CA2165829A1 (en) | 1993-07-01 | 1995-01-19 | John E. Abele | Imaging, electrical potential sensing, and ablation catheters |
US5487757A (en) | 1993-07-20 | 1996-01-30 | Medtronic Cardiorhythm | Multicurve deflectable catheter |
US5545200A (en) | 1993-07-20 | 1996-08-13 | Medtronic Cardiorhythm | Steerable electrophysiology catheter |
US5405374A (en) | 1993-08-25 | 1995-04-11 | Medtronic, Inc. | Transvenous defibrillation lead and method of use |
US5807395A (en) | 1993-08-27 | 1998-09-15 | Medtronic, Inc. | Method and apparatus for RF ablation and hyperthermia |
US5980516A (en) | 1993-08-27 | 1999-11-09 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5427118A (en) | 1993-10-04 | 1995-06-27 | Baxter International Inc. | Ultrasonic guidewire |
US5673695A (en) | 1995-08-02 | 1997-10-07 | Ep Technologies, Inc. | Methods for locating and ablating accessory pathways in the heart |
US5582609A (en) | 1993-10-14 | 1996-12-10 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
EP0754075B1 (en) | 1993-10-14 | 2006-03-15 | Boston Scientific Limited | Electrode elements for forming lesion patterns |
US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
US5575810A (en) | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
WO1995010225A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Multiple electrode element for mapping and ablating |
US5571147A (en) | 1993-11-02 | 1996-11-05 | Sluijter; Menno E. | Thermal denervation of an intervertebral disc for relief of back pain |
US5575766A (en) | 1993-11-03 | 1996-11-19 | Daig Corporation | Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers |
US5497774A (en) | 1993-11-03 | 1996-03-12 | Daig Corporation | Guiding introducer for left atrium |
US5564440A (en) | 1993-11-03 | 1996-10-15 | Daig Corporation | Method for mopping and/or ablation of anomalous conduction pathways |
US5507743A (en) | 1993-11-08 | 1996-04-16 | Zomed International | Coiled RF electrode treatment apparatus |
US5599345A (en) | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment apparatus |
WO1995013111A1 (en) | 1993-11-10 | 1995-05-18 | Medtronic Cadiorhythm | Electrode array catheter |
US5730127A (en) | 1993-12-03 | 1998-03-24 | Avitall; Boaz | Mapping and ablation catheter system |
US5487385A (en) | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
US6099524A (en) | 1994-01-28 | 2000-08-08 | Cardiac Pacemakers, Inc. | Electrophysiological mapping and ablation catheter and method |
US5462545A (en) | 1994-01-31 | 1995-10-31 | New England Medical Center Hospitals, Inc. | Catheter electrodes |
US5505201A (en) | 1994-04-20 | 1996-04-09 | Case Western Reserve University | Implantable helical spiral cuff electrode |
US5882333A (en) | 1994-05-13 | 1999-03-16 | Cardima, Inc. | Catheter with deflectable distal section |
US5617854A (en) | 1994-06-22 | 1997-04-08 | Munsif; Anand | Shaped catheter device and method |
US6405732B1 (en) | 1994-06-24 | 2002-06-18 | Curon Medical, Inc. | Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors |
US6009877A (en) | 1994-06-24 | 2000-01-04 | Edwards; Stuart D. | Method for treating a sphincter |
CA2194062C (en) | 1994-06-27 | 2005-06-28 | Dorin Panescu | System for controlling tissue ablation using temperature sensors |
EP0768842A4 (en) * | 1994-06-27 | 1998-05-13 | Ep Technologies | Systems and methods for sensing temperature within the body |
US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
US5690611A (en) | 1994-07-08 | 1997-11-25 | Daig Corporation | Process for the treatment of atrial arrhythima using a catheter guided by shaped giding introducers |
US5476498A (en) | 1994-08-15 | 1995-12-19 | Incontrol, Inc. | Coronary sinus channel lead and method |
US5609151A (en) | 1994-09-08 | 1997-03-11 | Medtronic, Inc. | Method for R-F ablation |
US5519172A (en) | 1994-09-13 | 1996-05-21 | W. L. Gore & Associates, Inc. | Jacket material for protection of electrical conductors |
US5545475A (en) | 1994-09-20 | 1996-08-13 | W. L. Gore & Associates | Microfiber-reinforced porous polymer film and a method for manufacturing the same and composites made thereof |
US5509909A (en) | 1994-10-06 | 1996-04-23 | Moy; Grant G. | Bent chest tube assembly |
US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
US6142994A (en) | 1994-10-07 | 2000-11-07 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body |
US5722401A (en) | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
GB9501424D0 (en) | 1995-01-25 | 1995-03-15 | Carrie Len | Epidural catheter |
DE19507929A1 (en) | 1995-02-24 | 1996-09-05 | Biotronik Mess & Therapieg | Electrode system for measuring the monophasic action potential |
WO1996026671A1 (en) | 1995-02-28 | 1996-09-06 | Boston Scientific Corporation | Polymeric implements for torque transmission |
WO1996028115A1 (en) | 1995-03-10 | 1996-09-19 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US5676662A (en) | 1995-03-17 | 1997-10-14 | Daig Corporation | Ablation catheter |
NL1000183C2 (en) | 1995-04-20 | 1996-10-22 | Clemens Josephus Jacobs | Catheter. |
US5681280A (en) | 1995-05-02 | 1997-10-28 | Heart Rhythm Technologies, Inc. | Catheter control system |
ATE308930T1 (en) | 1995-05-04 | 2005-11-15 | Sherwood Serv Ag | THERMO-SURGERY SYSTEM WITH COLD ELECTRIC TIP |
AU5956896A (en) | 1995-06-02 | 1996-12-18 | Guided Medical Systems, Inc. | Composite guide catheter of adjustable shape |
US6149620A (en) | 1995-11-22 | 2000-11-21 | Arthrocare Corporation | System and methods for electrosurgical tissue treatment in the presence of electrically conductive fluid |
US6090104A (en) | 1995-06-07 | 2000-07-18 | Cordis Webster, Inc. | Catheter with a spirally wound flat ribbon electrode |
US6322558B1 (en) | 1995-06-09 | 2001-11-27 | Engineering & Research Associates, Inc. | Apparatus and method for predicting ablation depth |
US5672174A (en) | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5707400A (en) | 1995-09-19 | 1998-01-13 | Cyberonics, Inc. | Treating refractory hypertension by nerve stimulation |
US6283951B1 (en) | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
US5700282A (en) | 1995-10-13 | 1997-12-23 | Zabara; Jacob | Heart rhythm stabilization using a neurocybernetic prosthesis |
US5823955A (en) | 1995-11-20 | 1998-10-20 | Medtronic Cardiorhythm | Atrioventricular valve tissue ablation catheter and method |
SE9504333D0 (en) | 1995-12-04 | 1995-12-04 | Pacesetter Ab | Guidewire assembly |
DE19546941A1 (en) | 1995-12-15 | 1997-06-19 | Biotronik Mess & Therapieg | Single electrode for two-chamber pacemaker systems, especially for DDD pacemaker systems |
US5895398A (en) | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US6436056B1 (en) | 1996-02-28 | 2002-08-20 | Boston Scientific Corporation | Polymeric implements for torque transmission |
US6036687A (en) | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US6032077A (en) | 1996-03-06 | 2000-02-29 | Cardiac Pathways Corporation | Ablation catheter with electrical coupling via foam drenched with a conductive fluid |
US5755760A (en) | 1996-03-11 | 1998-05-26 | Medtronic, Inc. | Deflectable catheter |
US5997526A (en) | 1996-03-25 | 1999-12-07 | The Uab Research Foundation | Shape memory catheter |
US5755761A (en) | 1996-04-26 | 1998-05-26 | Pharmatarget, Inc. | Atrial pacing catheter and method having multiple electrodes in the right atrium and coronary sinus |
US6042578A (en) | 1996-05-13 | 2000-03-28 | Schneider (Usa) Inc. | Catheter reinforcing braids |
US6223070B1 (en) | 1998-03-16 | 2001-04-24 | Cook, Inc. | Indwelling catheter |
US5727555A (en) | 1996-06-18 | 1998-03-17 | Cook Incorporated | Indwelling catheter |
US6546280B2 (en) | 1996-06-18 | 2003-04-08 | Cook Incorporated | Indwelling catheter |
US5827242A (en) | 1996-06-21 | 1998-10-27 | Medtronic, Inc. | Reinforced catheter body and method for its fabrication |
US5944710A (en) | 1996-06-24 | 1999-08-31 | Genetronics, Inc. | Electroporation-mediated intravascular delivery |
US5983141A (en) | 1996-06-27 | 1999-11-09 | Radionics, Inc. | Method and apparatus for altering neural tissue function |
US6246912B1 (en) | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
US5882346A (en) | 1996-07-15 | 1999-03-16 | Cardiac Pathways Corporation | Shapable catheter using exchangeable core and method of use |
US5972019A (en) | 1996-07-25 | 1999-10-26 | Target Therapeutics, Inc. | Mechanical clot treatment device |
US5800494A (en) | 1996-08-20 | 1998-09-01 | Fidus Medical Technology Corporation | Microwave ablation catheters having antennas with distal fire capabilities |
US5697928A (en) | 1996-09-23 | 1997-12-16 | Uab Research Foundation | Cardic electrode catheter |
US5891134A (en) | 1996-09-24 | 1999-04-06 | Goble; Colin | System and method for applying thermal energy to tissue |
US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
US6096036A (en) | 1998-05-05 | 2000-08-01 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
US5827268A (en) | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
US5893885A (en) | 1996-11-01 | 1999-04-13 | Cordis Webster, Inc. | Multi-electrode ablation catheter |
US6091995A (en) | 1996-11-08 | 2000-07-18 | Surx, Inc. | Devices, methods, and systems for shrinking tissues |
US5931848A (en) | 1996-12-02 | 1999-08-03 | Angiotrax, Inc. | Methods for transluminally performing surgery |
US5954719A (en) | 1996-12-11 | 1999-09-21 | Irvine Biomedical, Inc. | System for operating a RF ablation generator |
US6076012A (en) | 1996-12-19 | 2000-06-13 | Ep Technologies, Inc. | Structures for supporting porous electrode elements |
US5910129A (en) | 1996-12-19 | 1999-06-08 | Ep Technologies, Inc. | Catheter distal assembly with pull wires |
US6048329A (en) | 1996-12-19 | 2000-04-11 | Ep Technologies, Inc. | Catheter distal assembly with pull wires |
SE9700373L (en) | 1997-02-04 | 1998-07-13 | Stig Bengmark | Probe for providing fluid communication with the small intestine |
US5873865A (en) | 1997-02-07 | 1999-02-23 | Eclipse Surgical Technologies, Inc. | Spiral catheter with multiple guide holes |
US5730741A (en) | 1997-02-07 | 1998-03-24 | Eclipse Surgical Technologies, Inc. | Guided spiral catheter |
AU6156198A (en) | 1997-02-12 | 1998-08-26 | Oratec Interventions, Inc. | Concave probe for arthroscopic surgery |
US6086582A (en) | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
US5954761A (en) | 1997-03-25 | 1999-09-21 | Intermedics Inc. | Implantable endocardial lead assembly having a stent |
AU6112798A (en) | 1997-03-31 | 1998-10-22 | Biosense, Inc. | Deflectable catheter |
JP3274384B2 (en) | 1997-03-31 | 2002-04-15 | 株式会社パイオラックス | Indwelling catheter and its insertion device |
US5879295A (en) | 1997-04-02 | 1999-03-09 | Medtronic, Inc. | Enhanced contact steerable bowing electrode catheter assembly |
US5876373A (en) | 1997-04-04 | 1999-03-02 | Eclipse Surgical Technologies, Inc. | Steerable catheter |
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US5972026A (en) | 1997-04-07 | 1999-10-26 | Broncus Technologies, Inc. | Bronchial stenter having diametrically adjustable electrodes |
US5865815A (en) | 1997-04-25 | 1999-02-02 | Contimed, Inc. | Prostatic obstruction relief catheter |
US6078840A (en) | 1997-04-30 | 2000-06-20 | Medtronic, Inc. | Medical electrical lead having improved fixation |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6152912A (en) | 1997-06-10 | 2000-11-28 | Target Therapeutics, Inc. | Optimized high performance spiral-wound vascular catheter |
US5951539A (en) | 1997-06-10 | 1999-09-14 | Target Therpeutics, Inc. | Optimized high performance multiple coil spiral-wound vascular catheter |
WO1999000060A1 (en) | 1997-06-26 | 1999-01-07 | Advanced Coronary Intervention | Electrosurgical catheter for resolving obstructions by radio frequency ablation |
USRE40279E1 (en) | 1997-06-26 | 2008-04-29 | Sherwood Services Ag | Method and system for neural tissue modification |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6869431B2 (en) | 1997-07-08 | 2005-03-22 | Atrionix, Inc. | Medical device with sensor cooperating with expandable member |
US6514249B1 (en) | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
ATE433306T1 (en) | 1997-07-08 | 2009-06-15 | Univ California | DEVICE FOR CIRCUMFERENTIAL ABLATION |
US6164283A (en) | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6125302A (en) | 1997-09-02 | 2000-09-26 | Advanced Bionics Corporation | Precurved modiolar-hugging cochlear electrode |
US5871531A (en) | 1997-09-25 | 1999-02-16 | Medtronic, Inc. | Medical electrical lead having tapered spiral fixation |
US5891114A (en) | 1997-09-30 | 1999-04-06 | Target Therapeutics, Inc. | Soft-tip high performance braided catheter |
US6078830A (en) * | 1997-10-01 | 2000-06-20 | Ep Technologies, Inc. | Molded catheter distal end assembly and process for the manufacture thereof |
AU1190699A (en) | 1997-10-20 | 1999-05-10 | Robert D. Bersin | Helical spiral balloon catheter |
US6156046A (en) | 1997-11-07 | 2000-12-05 | Prolifix Medical, Inc. | Methods and systems for treating obstructions in a body lumen |
EP1030610A1 (en) | 1997-11-07 | 2000-08-30 | Prolifix Medical, Inc. | Methods and systems for treating obstructions in a body lumen |
US6120500A (en) | 1997-11-12 | 2000-09-19 | Daig Corporation | Rail catheter ablation and mapping system |
US6120476A (en) | 1997-12-01 | 2000-09-19 | Cordis Webster, Inc. | Irrigated tip catheter |
US6917834B2 (en) | 1997-12-03 | 2005-07-12 | Boston Scientific Scimed, Inc. | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates |
US6280441B1 (en) | 1997-12-15 | 2001-08-28 | Sherwood Services Ag | Apparatus and method for RF lesioning |
US6273886B1 (en) | 1998-02-19 | 2001-08-14 | Curon Medical, Inc. | Integrated tissue heating and cooling apparatus |
US6142993A (en) | 1998-02-27 | 2000-11-07 | Ep Technologies, Inc. | Collapsible spline structure using a balloon as an expanding actuator |
US6308090B1 (en) | 1998-03-09 | 2001-10-23 | Irvine Biomedical, Inc. | Devices and methods for coronary sinus mapping |
US5951471A (en) | 1998-03-09 | 1999-09-14 | Irvine Biomedical, Inc. | Catheter-based coronary sinus mapping and ablation |
US6132456A (en) | 1998-03-10 | 2000-10-17 | Medtronic, Inc. | Arrangement for implanting an endocardial cardiac lead |
US6078841A (en) | 1998-03-27 | 2000-06-20 | Advanced Bionics Corporation | Flexible positioner for use with implantable cochlear electrode array |
US6071729A (en) | 1998-04-02 | 2000-06-06 | Jeffries; Thomas W. | Disruption of the cytochrome C gene in xylose-fermenting yeast |
US6314325B1 (en) | 1998-04-07 | 2001-11-06 | William R. Fitz | Nerve hyperpolarization method and apparatus for pain relief |
WO1999052421A1 (en) | 1998-04-13 | 1999-10-21 | Prolifix Medical, Inc. | Guidewire for precision catheter positioning |
US6219577B1 (en) | 1998-04-14 | 2001-04-17 | Global Vascular Concepts, Inc. | Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues |
US6064902A (en) | 1998-04-16 | 2000-05-16 | C.R. Bard, Inc. | Pulmonary vein ablation catheter |
US5968085A (en) | 1998-04-20 | 1999-10-19 | Medtronic, Inc. | Pacing lead with integral guidance using ultrasound |
EP0951920B1 (en) | 1998-04-22 | 2004-10-20 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Electrode cable for attachement to a vessel wall |
US6511492B1 (en) | 1998-05-01 | 2003-01-28 | Microvention, Inc. | Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders |
US6146381A (en) | 1998-05-05 | 2000-11-14 | Cardiac Pacemakers, Inc. | Catheter having distal region for deflecting axial forces |
US6592581B2 (en) | 1998-05-05 | 2003-07-15 | Cardiac Pacemakers, Inc. | Preformed steerable catheter with movable outer sleeve and method for use |
US6074339A (en) | 1998-05-07 | 2000-06-13 | Medtronic Ave, Inc. | Expandable braid device and method for radiation treatment |
US6231572B1 (en) | 1998-05-29 | 2001-05-15 | Applied Medical Resources Corporation | Electrosurgical catheter apparatus and method |
US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US6292695B1 (en) | 1998-06-19 | 2001-09-18 | Wilton W. Webster, Jr. | Method and apparatus for transvascular treatment of tachycardia and fibrillation |
US6094596A (en) | 1998-06-19 | 2000-07-25 | Angeron Corporation | Transvenous defibrillation lead system for use in middle cardiac vein |
US6302903B1 (en) | 1998-07-07 | 2001-10-16 | Medtronic, Inc. | Straight needle apparatus for creating a virtual electrode used for the ablation of tissue |
US6179860B1 (en) | 1998-08-19 | 2001-01-30 | Artemis Medical, Inc. | Target tissue localization device and method |
US6610083B2 (en) | 1998-08-24 | 2003-08-26 | Radiant Medical, Inc. | Multiple lumen heat exchange catheters |
US6228109B1 (en) | 1998-08-31 | 2001-05-08 | Lily Chen Tu | Methods for treating atherosclerosis and vulnerable plaques |
US6123702A (en) | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6385472B1 (en) | 1999-09-10 | 2002-05-07 | Stereotaxis, Inc. | Magnetically navigable telescoping catheter and method of navigating telescoping catheter |
US6701176B1 (en) | 1998-11-04 | 2004-03-02 | Johns Hopkins University School Of Medicine | Magnetic-resonance-guided imaging, electrophysiology, and ablation |
US7313444B2 (en) | 1998-11-20 | 2007-12-25 | Pacesetter, Inc. | Self-anchoring coronary sinus lead |
EP1140278B1 (en) | 1998-12-14 | 2004-05-19 | Tre Esse Progettazione Biomedica S.r.l | Catheter system for performing intramyocardiac therapeutic treatment |
US20070066972A1 (en) | 2001-11-29 | 2007-03-22 | Medwaves, Inc. | Ablation catheter apparatus with one or more electrodes |
US6210408B1 (en) | 1999-02-24 | 2001-04-03 | Scimed Life Systems, Inc. | Guide wire system for RF recanalization of vascular blockages |
ATE298536T1 (en) | 1999-03-09 | 2005-07-15 | Thermage Inc | DEVICE FOR TREATING TISSUE |
US6129750A (en) | 1999-03-23 | 2000-10-10 | Cardiac Pacemakers, Inc. | Fixation mechanism for a coronary venous pacing lead |
US6161049A (en) | 1999-03-26 | 2000-12-12 | Urologix, Inc. | Thermal therapy catheter |
US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
US20050010095A1 (en) * | 1999-04-05 | 2005-01-13 | Medtronic, Inc. | Multi-purpose catheter apparatus and method of use |
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
US20010007070A1 (en) | 1999-04-05 | 2001-07-05 | Medtronic, Inc. | Ablation catheter assembly and method for isolating a pulmonary vein |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US6939346B2 (en) | 1999-04-21 | 2005-09-06 | Oratec Interventions, Inc. | Method and apparatus for controlling a temperature-controlled probe |
EP1092449A1 (en) | 1999-04-30 | 2001-04-18 | Usaminanotechnology, Inc. | Catheter and guide wire |
WO2000066017A1 (en) | 1999-05-04 | 2000-11-09 | Curon Medical, Inc. | Electrodes for creating lesions in tissue regions at or near a sphincter |
US6758830B1 (en) | 1999-05-11 | 2004-07-06 | Atrionix, Inc. | Catheter positioning system |
ATE353001T1 (en) | 1999-05-11 | 2007-02-15 | Atrionix Inc | BALLOON ANCHORING WIRE |
US6692490B1 (en) | 1999-05-18 | 2004-02-17 | Novasys Medical, Inc. | Treatment of urinary incontinence and other disorders by application of energy and drugs |
DE29909082U1 (en) | 1999-05-25 | 1999-07-22 | Starck | Stimulation, sensing and / or defibrillation electrode and balloon catheter for inserting the electrode |
US7171263B2 (en) | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
US6890329B2 (en) | 1999-06-15 | 2005-05-10 | Cryocath Technologies Inc. | Defined deflection structure |
US6546272B1 (en) | 1999-06-24 | 2003-04-08 | Mackinnon Nicholas B. | Apparatus for in vivo imaging of the respiratory tract and other internal organs |
US7840278B1 (en) | 1999-06-25 | 2010-11-23 | Puskas John D | Devices and methods for vagus nerve stimulation |
US6620172B1 (en) | 1999-07-01 | 2003-09-16 | Medsource Technologies, Inc. | Entraining biological calculi |
US6364904B1 (en) | 1999-07-02 | 2002-04-02 | Scimed Life Systems, Inc. | Helically formed stent/graft assembly |
US6605061B2 (en) | 1999-07-14 | 2003-08-12 | Tricardia, L.L.C. | Catheter for drug injection in cardiovascular system |
US6508804B2 (en) | 1999-07-28 | 2003-01-21 | Scimed Life Systems, Inc. | Catheter having continuous lattice and coil reinforcement |
US6442415B1 (en) | 1999-08-12 | 2002-08-27 | Magnetic Moments, L.L.C. | Contrast-enhanced coronary artery and coronary artery bypass graft imaging using an aortic root catheter injection with either magnetic resonance angiography or computed tomographic angiography |
US6607520B2 (en) | 1999-09-15 | 2003-08-19 | The General Hospital Corporation | Coiled ablation catheter system |
US6454775B1 (en) | 1999-12-06 | 2002-09-24 | Bacchus Vascular Inc. | Systems and methods for clot disruption and retrieval |
JP2003510126A (en) | 1999-09-28 | 2003-03-18 | ノヴァシス メディカル インコーポレイテッド | Tissue treatment by application of energy and drugs |
US6613046B1 (en) | 1999-11-22 | 2003-09-02 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
CA2391488C (en) | 1999-11-22 | 2012-04-03 | Boston Scientific Limited | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US6542781B1 (en) | 1999-11-22 | 2003-04-01 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US6711444B2 (en) | 1999-11-22 | 2004-03-23 | Scimed Life Systems, Inc. | Methods of deploying helical diagnostic and therapeutic element supporting structures within the body |
US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6745080B2 (en) | 1999-11-22 | 2004-06-01 | Scimed Life Systems, Inc. | Helical and pre-oriented loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
DE10042330A1 (en) | 1999-12-22 | 2002-03-14 | Hans Sachse | Small intestine probe, wall-reinforced |
US6885888B2 (en) | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
US6628976B1 (en) | 2000-01-27 | 2003-09-30 | Biosense Webster, Inc. | Catheter having mapping assembly |
US6514226B1 (en) | 2000-02-10 | 2003-02-04 | Chf Solutions, Inc. | Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney |
US7163504B1 (en) | 2000-02-16 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Multi-lumen fluted balloon radiation centering catheter |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
US6652517B1 (en) | 2000-04-25 | 2003-11-25 | Uab Research Foundation | Ablation catheter, system, and method of use thereof |
EP1642544B1 (en) | 2000-05-03 | 2009-04-08 | C.R.Bard, Inc. | Apparatus for mapping and ablation in electrophysiology procedures |
ATE290827T1 (en) | 2000-06-13 | 2005-04-15 | Atrionix Inc | SURGICAL ABLATION PROBE FOR FORMING AN ANNUAL LESION |
AU2001287574A1 (en) | 2000-06-30 | 2002-01-08 | Ingenium Pharmaceuticals Ag | Human g protein-coupled receptor igpcr20, and uses thereof |
US6635054B2 (en) | 2000-07-13 | 2003-10-21 | Transurgical, Inc. | Thermal treatment methods and apparatus with focused energy application |
US7158832B2 (en) | 2000-09-27 | 2007-01-02 | Cvrx, Inc. | Electrode designs and methods of use for cardiovascular reflex control devices |
US6850801B2 (en) | 2001-09-26 | 2005-02-01 | Cvrx, Inc. | Mapping methods for cardiovascular reflex control devices |
US6985774B2 (en) | 2000-09-27 | 2006-01-10 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
US6522926B1 (en) | 2000-09-27 | 2003-02-18 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control |
US6845267B2 (en) | 2000-09-28 | 2005-01-18 | Advanced Bionics Corporation | Systems and methods for modulation of circulatory perfusion by electrical and/or drug stimulation |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US6640120B1 (en) | 2000-10-05 | 2003-10-28 | Scimed Life Systems, Inc. | Probe assembly for mapping and ablating pulmonary vein tissue and method of using same |
US6926669B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
US6802857B1 (en) | 2000-10-11 | 2004-10-12 | Uab Research Foundation | MRI stent |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US7646544B2 (en) | 2005-05-14 | 2010-01-12 | Batchko Robert G | Fluidic optical devices |
US6616624B1 (en) | 2000-10-30 | 2003-09-09 | Cvrx, Inc. | Systems and method for controlling renovascular perfusion |
US6579308B1 (en) | 2000-11-28 | 2003-06-17 | Scimed Life Systems, Inc. | Stent devices with detachable distal or proximal wires |
US6676657B2 (en) | 2000-12-07 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Endoluminal radiofrequency cauterization system |
US6554827B2 (en) | 2000-12-11 | 2003-04-29 | Scimed Life Systems, Inc. | Radio frequency ablation system |
US20020087151A1 (en) | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
US6527739B1 (en) | 2000-12-29 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Spiraled balloon arrangement for treatment of a tortuous vessel |
EP1363700A4 (en) | 2001-01-11 | 2005-11-09 | Rita Medical Systems Inc | Bone-treatment instrument and method |
US6480747B2 (en) | 2001-01-16 | 2002-11-12 | Quetzal Biomedical, Inc. | Cardiac electrode catheter and method of manufacturing same |
US6451045B1 (en) | 2001-02-22 | 2002-09-17 | Alsius Corporation | Heat exchange catheter having a helically wrapped heat exchanger |
US6564096B2 (en) | 2001-02-28 | 2003-05-13 | Robert A. Mest | Method and system for treatment of tachycardia and fibrillation |
DE10114725A1 (en) | 2001-03-21 | 2002-09-26 | Biotronik Mess & Therapieg | Intravascular lead |
DE60223794T2 (en) | 2001-04-27 | 2008-10-30 | C.R. Bard, Inc. | ELECTROPHYSIOLOGY CATHETERS FOR MAPPING AND ABLATION |
US6909920B2 (en) | 2001-04-27 | 2005-06-21 | Medtronic, Inc. | System and method for positioning an implantable medical device within a body |
US6972016B2 (en) | 2001-05-01 | 2005-12-06 | Cardima, Inc. | Helically shaped electrophysiology catheter |
US20020169444A1 (en) | 2001-05-08 | 2002-11-14 | Mest Robert A. | Catheter having continuous braided electrode |
WO2002089908A1 (en) | 2001-05-10 | 2002-11-14 | Super Dimension Ltd. | Steerable multiple electrode catheter and method |
US20030050635A1 (en) | 2001-08-22 | 2003-03-13 | Csaba Truckai | Embolization systems and techniques for treating tumors |
US7778703B2 (en) | 2001-08-31 | 2010-08-17 | Bio Control Medical (B.C.M.) Ltd. | Selective nerve fiber stimulation for treating heart conditions |
US20030065317A1 (en) | 2001-09-19 | 2003-04-03 | Rudie Eric N. | Microwave ablation device |
JP3607231B2 (en) | 2001-09-28 | 2005-01-05 | 有限会社日本エレクテル | High frequency heating balloon catheter |
US7517349B2 (en) | 2001-10-22 | 2009-04-14 | Vnus Medical Technologies, Inc. | Electrosurgical instrument and method |
AU2002359576A1 (en) | 2001-12-03 | 2003-06-17 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US20030125790A1 (en) | 2001-12-27 | 2003-07-03 | Vitaly Fastovsky | Deployment device, system and method for medical implantation |
US6893436B2 (en) | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
US6817999B2 (en) | 2002-01-03 | 2004-11-16 | Afx, Inc. | Flexible device for ablation of biological tissue |
US6814733B2 (en) | 2002-01-31 | 2004-11-09 | Biosense, Inc. | Radio frequency pulmonary vein isolation |
US7311705B2 (en) | 2002-02-05 | 2007-12-25 | Medtronic, Inc. | Catheter apparatus for treatment of heart arrhythmia |
US7236821B2 (en) | 2002-02-19 | 2007-06-26 | Cardiac Pacemakers, Inc. | Chronically-implanted device for sensing and therapy |
ITBS20020039U1 (en) | 2002-03-20 | 2003-09-22 | Fogazzi Di Venturelli Andrea & | CATHETER WITH FLEXIBLE COOLED ELECTRODE |
US6736835B2 (en) | 2002-03-21 | 2004-05-18 | Depuy Acromed, Inc. | Early intervention spinal treatment methods and devices for use therein |
WO2003082403A2 (en) | 2002-03-27 | 2003-10-09 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control via coupled electrodes |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8175711B2 (en) | 2002-04-08 | 2012-05-08 | Ardian, Inc. | Methods for treating a condition or disease associated with cardio-renal function |
DE10218427A1 (en) | 2002-04-24 | 2003-11-06 | Biotronik Mess & Therapieg | Ablation device for cardiac tissue, in particular for creating a circular lesion around a vascular mouth in the heart |
US6746474B2 (en) | 2002-05-31 | 2004-06-08 | Vahid Saadat | Apparatus and methods for cooling a region within the body |
US6748953B2 (en) | 2002-06-11 | 2004-06-15 | Scimed Life Systems, Inc. | Method for thermal treatment of type II endoleaks in arterial aneurysms |
US7115134B2 (en) | 2002-07-22 | 2006-10-03 | Chambers Technology, Llc. | Catheter with flexible tip and shape retention |
WO2004011076A2 (en) | 2002-07-25 | 2004-02-05 | Boston Scientific Limited | Medical device for navigation through anatomy and method of making same |
US7058456B2 (en) | 2002-08-09 | 2006-06-06 | Concentric Medical, Inc. | Methods and devices for changing the shape of a medical device |
US6780183B2 (en) | 2002-09-16 | 2004-08-24 | Biosense Webster, Inc. | Ablation catheter having shape-changing balloon |
US7282213B2 (en) | 2002-09-30 | 2007-10-16 | Medtronic, Inc. | Method for applying a drug coating to a medical device |
US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
EP3097882A1 (en) | 2002-10-31 | 2016-11-30 | Boston Scientific Scimed, Inc. | Improved electrophysiology loop catheter |
DE10257146A1 (en) | 2002-12-06 | 2004-06-24 | Admedes Schuessler Gmbh | Thermal ablation probe for minimal invasive body tissue high frequency thermal treatment has temperature sensor on star shaped flexible arms with adjustable protrusion from insulating sheath |
DE10252325B4 (en) | 2002-11-11 | 2012-10-25 | Admedes Schuessler Gmbh | Radiofrequency thermal ablation probe and method of making the same |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US7890188B2 (en) | 2002-12-19 | 2011-02-15 | Cardiac Pacemakers, Inc. | Implantable lead for septal placement of electrode with fixation mechanism in the pulmonary artery |
US6847848B2 (en) | 2003-01-07 | 2005-01-25 | Mmtc, Inc | Inflatable balloon catheter structural designs and methods for treating diseased tissue of a patient |
US6960207B2 (en) | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
US7013169B2 (en) | 2003-01-27 | 2006-03-14 | Cardiac Pacemakers, Inc. | Dual steer preshaped catheter |
WO2006020920A2 (en) | 2003-01-29 | 2006-02-23 | Medtronic, Inc. | Catheter apparatus for treatment of heart arrhythmia |
US6941953B2 (en) | 2003-02-20 | 2005-09-13 | Medwaves, Inc. | Preformed catheter set for use with a linear ablation system to produce ablation lines in the left and right atrium for treatment of atrial fibrillation |
US6923808B2 (en) | 2003-02-24 | 2005-08-02 | Boston Scientific Scimed, Inc. | Probes having helical and loop shaped inflatable therapeutic elements |
WO2004078066A2 (en) | 2003-03-03 | 2004-09-16 | Sinus Rhythm Technologies, Inc. | Primary examiner |
US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
US7221979B2 (en) | 2003-04-30 | 2007-05-22 | Medtronic, Inc. | Methods and apparatus for the regulation of hormone release |
JP4212949B2 (en) | 2003-05-06 | 2009-01-21 | 朝日インテック株式会社 | Chemical injection device |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
US7789877B2 (en) | 2003-07-02 | 2010-09-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter electrode arrangement |
US7670335B2 (en) | 2003-07-21 | 2010-03-02 | Biosense Webster, Inc. | Ablation device with spiral array ultrasound transducer |
EP3045136B1 (en) | 2003-09-12 | 2021-02-24 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US7435248B2 (en) | 2003-09-26 | 2008-10-14 | Boston Scientific Scimed, Inc. | Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel |
US7416549B2 (en) | 2003-10-10 | 2008-08-26 | Boston Scientific Scimed, Inc. | Multi-zone bipolar ablation probe assembly |
US7480532B2 (en) | 2003-10-22 | 2009-01-20 | Cvrx, Inc. | Baroreflex activation for pain control, sedation and sleep |
US7254451B2 (en) | 2003-11-20 | 2007-08-07 | Medtronic, Inc. | Implantable lead including sensor |
EP1686909B1 (en) | 2003-11-25 | 2018-08-01 | Cathrx Ltd | A modular catheter |
AU2005207078B2 (en) | 2004-01-26 | 2011-03-17 | Cathrx Ltd | A catheter assembly with an adjustable loop |
US7637903B2 (en) | 2004-02-09 | 2009-12-29 | Cryocor, Inc. | Catheter articulation segment with alternating cuts |
US7231260B2 (en) | 2004-05-06 | 2007-06-12 | Boston Scientific Scimed, Inc. | Intravascular self-anchoring electrode body with arcuate springs, spring loops, or arms |
US20060085054A1 (en) | 2004-09-09 | 2006-04-20 | Zikorus Arthur W | Methods and apparatus for treatment of hollow anatomical structures |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US7542808B1 (en) | 2004-09-17 | 2009-06-02 | Cardiac Pacemakers, Inc. | Lead and catheter assembly |
US20060074403A1 (en) | 2004-09-29 | 2006-04-06 | Nasser Rafiee | Curved catheter comprising a solid-walled metal tube with varying stiffness |
US7524318B2 (en) | 2004-10-28 | 2009-04-28 | Boston Scientific Scimed, Inc. | Ablation probe with flared electrodes |
WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
US7402151B2 (en) | 2004-12-17 | 2008-07-22 | Biocardia, Inc. | Steerable guide catheters and methods for their use |
US8983582B2 (en) | 2004-12-20 | 2015-03-17 | Advanced Cardiovascular Systems, Inc. | Methods and apparatuses for positioning within an internal channel |
US20060135953A1 (en) | 2004-12-22 | 2006-06-22 | Wlodzimierz Kania | Tissue ablation system including guidewire with sensing element |
US20080300587A1 (en) | 2005-03-02 | 2008-12-04 | Cathrx Ltd | Heat Treatment Catheter |
CN101511292B (en) | 2005-03-28 | 2011-04-06 | 明诺医学有限公司 | Intraluminal electrical tissue characterization and tuned RF energy for selective treatment of atheroma and other target tissues |
US7806871B2 (en) | 2005-05-09 | 2010-10-05 | Boston Scientific Scimed, Inc. | Method and device for tissue removal and for delivery of a therapeutic agent or bulking agent |
EP1895927A4 (en) | 2005-06-20 | 2011-03-09 | Medtronic Ablation Frontiers | Ablation catheter |
WO2007002304A2 (en) | 2005-06-22 | 2007-01-04 | Vnus Medical Technologies, Inc. | Methods and apparatus for introducing tumescent fluid to body tissue |
US7717853B2 (en) | 2005-06-24 | 2010-05-18 | Henry Nita | Methods and apparatus for intracranial ultrasound delivery |
AU2006263448B2 (en) | 2005-06-29 | 2013-01-24 | Radiant Medical, Inc. | Devices, systems and methods for rapid endovascular cooling |
US7390894B2 (en) | 2005-07-07 | 2008-06-24 | Mayo Foundation For Medical Education And Research | Glutathione S-transferase sequence variants |
US8834461B2 (en) | 2005-07-11 | 2014-09-16 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
US8140170B2 (en) | 2005-09-12 | 2012-03-20 | The Cleveland Clinic Foundation | Method and apparatus for renal neuromodulation |
EP1946712B1 (en) * | 2005-11-01 | 2012-08-29 | Japan Electel Inc. | Balloon catheter system |
US7647124B2 (en) | 2005-11-15 | 2010-01-12 | Medtronic, Inc. | Delivery catheter |
US7729782B2 (en) | 2005-11-15 | 2010-06-01 | Medtronic, Inc. | Delivery catheter |
US7993334B2 (en) | 2005-12-29 | 2011-08-09 | Boston Scientific Scimed, Inc. | Low-profile, expanding single needle ablation probe |
US20070225781A1 (en) | 2006-03-21 | 2007-09-27 | Nidus Medical, Llc | Apparatus and methods for altering temperature in a region within the body |
US7747334B2 (en) | 2006-03-23 | 2010-06-29 | Cardiac Pacemakers, Inc. | Left ventricular lead shapes |
US7579550B2 (en) | 2006-03-31 | 2009-08-25 | Boston Scientific Scimed, Inc. | Flexible device shaft with angled spiral wrap |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
WO2007128064A1 (en) | 2006-05-08 | 2007-11-15 | Cathrx Ltd | Shape imparting mechanism insertion |
US7708704B2 (en) | 2006-07-31 | 2010-05-04 | Codman & Shurtleff, Pc | Interventional medical device component having an interrupted spiral section and method of making the same |
US20080064957A1 (en) | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US8317773B2 (en) | 2006-11-07 | 2012-11-27 | Angio Dynamics, Inc. | Catheter with open faced sloped end portion |
US8915926B2 (en) | 2006-11-08 | 2014-12-23 | Advanced Bionics Ag | Pre-curved electrode array loading tools |
EP2094346A4 (en) | 2006-11-28 | 2010-05-19 | Cathrx Ltd | Catheter steering/insertion mechanism |
WO2008101244A2 (en) | 2007-02-18 | 2008-08-21 | Via Biomedical, Inc. | Guiding catheter support devices and methods |
US8103359B2 (en) | 2007-05-17 | 2012-01-24 | Cardiac Pacemakers, Inc. | Systems and methods for fixating transvenously implanted medical devices |
US8630704B2 (en) | 2007-06-25 | 2014-01-14 | Cardiac Pacemakers, Inc. | Neural stimulation with respiratory rhythm management |
US7863897B2 (en) | 2007-09-07 | 2011-01-04 | The General Hospital Corporation | Method and apparatus for characterizing the temporal resolution of an imaging device |
US8118809B2 (en) | 2007-12-21 | 2012-02-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Flexible conductive polymer electrode and method for ablation |
US20090247933A1 (en) | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California; Angiodynamics, Inc. | Balloon catheter method for reducing restenosis via irreversible electroporation |
US8480663B2 (en) | 2008-05-15 | 2013-07-09 | Boston Scientific Scimed, Inc. | Apparatus and methods for cryogenically ablating tissue and adjusting cryogenic ablation regions |
US8437832B2 (en) | 2008-06-06 | 2013-05-07 | Biosense Webster, Inc. | Catheter with bendable tip |
US8100859B2 (en) | 2008-06-24 | 2012-01-24 | Cook Medical Technologies Llc | Bent obturator |
US8123739B2 (en) | 2008-08-19 | 2012-02-28 | Cook Medical Technologies Llc | Drainage catheter and method for catheterizing a patient |
WO2010048676A1 (en) | 2008-10-31 | 2010-05-06 | Cathrx Ltd | A catheter assembly |
US20150105659A1 (en) | 2008-11-11 | 2015-04-16 | Covidien Lp | Energy delivery device and methods of use |
US11376061B2 (en) | 2008-11-11 | 2022-07-05 | Covidien Lp | Energy delivery device and methods of use |
US8317810B2 (en) | 2008-12-29 | 2012-11-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Tissue puncture assemblies and methods for puncturing tissue |
JP2012517306A (en) | 2009-02-12 | 2012-08-02 | イューエムセー ユトレヒト ホールディング ベースローテン フェンノートシャップ | Ablation catheter and method for electrically insulating heart tissue |
US8929969B2 (en) | 2009-04-14 | 2015-01-06 | Medtronic Ablation Frontiers Llc | Catheter assembly and associated method |
US20120035615A1 (en) | 2009-05-22 | 2012-02-09 | Advanced Bionics, Llc | Composite Stylet |
WO2011015218A1 (en) | 2009-08-06 | 2011-02-10 | Ls Medcap Gmbh | Catheter with two fenestrations |
JP5542937B2 (en) | 2009-08-14 | 2014-07-09 | ボストン サイエンティフィック サイムド,インコーポレイテッド | System and method for manufacturing and using a medical ablation system having a mapping catheter with improved anchor performance |
CN201469401U (en) | 2009-08-21 | 2010-05-19 | 刘小青 | Spiral renal-artery-around renal sympathetic nerve radio-frequency ablation electrode catheter |
US9011430B2 (en) | 2009-11-04 | 2015-04-21 | Emcision Limited | Lumenal remodeling device and methods |
KR101820542B1 (en) | 2009-11-11 | 2018-01-19 | 호라이라 인코포레이티드 | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US8920415B2 (en) | 2009-12-16 | 2014-12-30 | Biosense Webster (Israel) Ltd. | Catheter with helical electrode |
US8608735B2 (en) | 2009-12-30 | 2013-12-17 | Biosense Webster (Israel) Ltd. | Catheter with arcuate end section |
US20110263921A1 (en) | 2009-12-31 | 2011-10-27 | Anthony Vrba | Patterned Denervation Therapy for Innervated Renal Vasculature |
CA2792153C (en) | 2010-03-23 | 2018-05-15 | Boston Scientific Neuromodulation Corporation | Helical radial spacing of contacts on a cylindrical lead |
CA2793737A1 (en) | 2010-03-24 | 2011-09-29 | Shifamed Holdings, Llc | Intravascular tissue disruption |
EP2558016A2 (en) | 2010-04-14 | 2013-02-20 | Boston Scientific Scimed, Inc. | Renal artery denervation apparatus employing helical shaping arrangement |
US9108022B2 (en) | 2010-05-11 | 2015-08-18 | Cathrx Ltd | Catheter shape release mechanism |
US8753352B2 (en) | 2010-06-25 | 2014-06-17 | Advanced Bionics Ag | Tools, systems, and methods for inserting a pre-curved electrode array portion of a lead into a bodily orifice |
CA2746948C (en) * | 2010-07-21 | 2019-01-15 | Diros Technology Inc. | Advanced multi-purpose catheter probes for diagnostic and therapeutic procedures |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
EP3100696B1 (en) * | 2010-10-25 | 2023-01-11 | Medtronic Ardian Luxembourg S.à.r.l. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation |
US9060755B2 (en) * | 2010-10-26 | 2015-06-23 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
EP2645955B1 (en) | 2010-12-01 | 2016-10-26 | Boston Scientific Scimed, Inc. | Expandable angular vascular electrode for renal nerve ablation |
WO2012100211A2 (en) | 2011-01-20 | 2012-07-26 | Hansen Medical, Inc. | System and method for endoluminal and transluminal therapy |
EP2667812A1 (en) * | 2011-01-28 | 2013-12-04 | Medtronic Ardian Luxembourg S.à.r.l. | Ablation catheter equipped with a shape memory material |
WO2012130337A1 (en) | 2011-04-01 | 2012-10-04 | Flux Medical N.V. | System, device and method for ablation of a vessel's wall from the inside |
AU2012364793B2 (en) | 2011-04-08 | 2015-08-06 | Covidien Lp | Flexible microwave catheters for natural or artificial lumens |
WO2012149167A2 (en) | 2011-04-26 | 2012-11-01 | Christopher Gerard Kunis | Method and device for treatment of hypertension and other maladies |
CN102274075A (en) | 2011-05-03 | 2011-12-14 | 上海微创电生理医疗科技有限公司 | Multipolar punctiform electrode catheter for heat-induced kidney neuroregulation |
CN102198015B (en) | 2011-05-03 | 2013-11-06 | 上海微创电生理医疗科技有限公司 | Retractable spiral laminar ring type electrode catheter |
EP2706939A4 (en) | 2011-05-09 | 2015-05-27 | Cyberheart Inc | Renovascular treatment device, system and method for radiosurgicauy alleviating hypertension |
US20120290053A1 (en) | 2011-05-11 | 2012-11-15 | St. Jude Medical, Inc. | Renal nerve stimulation lead, delivery system, and method |
EP2709517B1 (en) | 2011-05-18 | 2017-01-11 | St. Jude Medical, Inc. | Apparatus for assessing transvascular denervation |
US8909316B2 (en) | 2011-05-18 | 2014-12-09 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method of assessing transvascular denervation |
CN103813829B (en) | 2011-07-22 | 2016-05-18 | 波士顿科学西美德公司 | There is the neuromodulation system of the neuromodulation element that can be positioned in spiral guiding piece |
WO2013028993A2 (en) | 2011-08-24 | 2013-02-28 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation |
US9022948B2 (en) | 2011-08-26 | 2015-05-05 | Symap Holding Limited | System and method for locating and identifying the functional nerves innervating the wall of arteries |
US8702619B2 (en) | 2011-08-26 | 2014-04-22 | Symap Holding Limited | Mapping sympathetic nerve distribution for renal ablation and catheters for same |
WO2013030807A2 (en) | 2011-09-01 | 2013-03-07 | Perseus-Biomed Inc. | Method and system for tissue modulation |
CA2847846A1 (en) | 2011-09-14 | 2013-03-21 | Boston Scientific Scimed, Inc. | Ablation device with multiple ablation modes |
US8387084B1 (en) | 2011-09-28 | 2013-02-26 | United Video Properties, Inc. | Systems and methods for detecting unauthorized use of a user equipment device |
US20140243821A1 (en) | 2011-09-30 | 2014-08-28 | Covidien Lp | Energy delivery device and methods of use |
US8498686B2 (en) | 2011-10-04 | 2013-07-30 | Biosense Webster (Israel), Ltd. | Mapping catheter with spiral electrode assembly |
US20130090637A1 (en) | 2011-10-05 | 2013-04-11 | St. Jude Medical, Inc. | Catheter device and method for denervation |
US20140350553A1 (en) | 2011-11-21 | 2014-11-27 | Denerve Inc. | Renal artery ablation catheter and system |
CN202386778U (en) | 2011-11-29 | 2012-08-22 | 北京天助畅运医疗技术股份有限公司 | Radio-frequency melting device |
US20130144283A1 (en) | 2011-12-02 | 2013-06-06 | Medtronic Ardian Luxembourg S.A.R.L. | Treatment of polycystic ovary syndrome using renal neuromodulation and associated systems and methods |
US9192766B2 (en) | 2011-12-02 | 2015-11-24 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and devices for treatment of polycystic kidney disease |
CN102488552B (en) | 2011-12-15 | 2015-04-15 | 四川锦江电子科技有限公司 | Manageable spiral electrophysiology catheter |
CN202426649U (en) | 2011-12-22 | 2012-09-12 | 王涛 | Ringlike multi-point radio-frequency ablation electrode |
CN104135958B (en) | 2011-12-28 | 2017-05-03 | 波士顿科学西美德公司 | By the apparatus and method that have the new ablation catheter modulation nerve of polymer ablation |
US20130172879A1 (en) | 2011-12-29 | 2013-07-04 | Boston Scientific Scimed, Inc. | Renal nerve modulation medical devices |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
EP2804554A1 (en) | 2012-01-17 | 2014-11-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods for making and using the same |
US8571654B2 (en) | 2012-01-17 | 2013-10-29 | Cyberonics, Inc. | Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction |
CN202538132U (en) | 2012-02-06 | 2012-11-21 | 北京中孵友信医药科技股份有限公司 | Snakelike intracavitary catheter |
AU2013230774B2 (en) | 2012-03-08 | 2015-12-03 | Medtronic Af Luxembourg S.A.R.L. | Gastrointestinal neuromodulation and associated systems and methods |
AU2013230893B2 (en) | 2012-03-08 | 2015-12-03 | Medtronic Af Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the management of pain |
US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
AU2013230906A1 (en) | 2012-03-08 | 2014-09-18 | Medtronic Af Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the treatment of sexual dysfunction |
US20130253628A1 (en) | 2012-03-22 | 2013-09-26 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation |
CN202537649U (en) | 2012-04-10 | 2012-11-21 | 北京中孵友信医药科技股份有限公司 | Intracavity catheter with global location function |
US20130274730A1 (en) | 2012-04-12 | 2013-10-17 | Boston Scientific Scimed, Inc. | Ablation catheter and methods for nerve modulation |
US9439598B2 (en) | 2012-04-12 | 2016-09-13 | NeuroMedic, Inc. | Mapping and ablation of nerves within arteries and tissues |
EP2836151B1 (en) | 2012-04-13 | 2016-10-26 | Covidien LP | Energy delivery device |
WO2013158676A2 (en) | 2012-04-16 | 2013-10-24 | Boston Scientific Scimed, Inc. | Renal nerve modulation catheter design |
CN104203136A (en) | 2012-04-16 | 2014-12-10 | 波士顿科学西美德公司 | Helical tubing devices for fluid renal nerve modulation |
US9113929B2 (en) | 2012-04-19 | 2015-08-25 | St. Jude Medical, Cardiology Division, Inc. | Non-electric field renal denervation electrode |
WO2013165920A1 (en) | 2012-04-29 | 2013-11-07 | Synecor Llc | Intravascular electrode arrays for neuromodulation |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9439722B2 (en) | 2012-05-09 | 2016-09-13 | Biosense Webster (Israel) Ltd. | Ablation targeting nerves in or near the inferior vena cava and/or abdominal aorta for treatment of hypertension |
CN102772249B (en) | 2012-06-19 | 2015-01-21 | 深圳市惠泰医疗器械有限公司 | Radiofrequency ablation electrode catheter of renal artery rail |
CN104540465A (en) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | Intravascular catheter with a balloon comprising separate microporous regions |
EP3123973A1 (en) | 2012-08-28 | 2017-02-01 | Boston Scientific Scimed, Inc. | Renal rf ablation system with a movable virtual electrode and related methods of use |
WO2014036160A2 (en) | 2012-08-28 | 2014-03-06 | Boston Scientific Scimed, Inc. | Renal nerve modulation and ablation catheter electrode design |
CN102908188B (en) | 2012-08-29 | 2015-04-08 | 中国人民解放军第三军医大学第一附属医院 | Radio frequency ablation (RFA) catheter system for denervation of renal sympathetic nerves |
CN102885648B (en) | 2012-08-29 | 2015-03-18 | 中国人民解放军第三军医大学第一附属医院 | Sympathetic nerve denervation ablation catheter system for kidneys |
CN202843784U (en) | 2012-08-29 | 2013-04-03 | 中国人民解放军第三军医大学第一附属医院 | Renal sympathetic nerve ablation catheter system |
CN202761434U (en) | 2012-08-29 | 2013-03-06 | 中国人民解放军第三军医大学第一附属医院 | Kidney sympathetic denervation multifunctional ablation catheter system |
WO2014056460A1 (en) | 2012-08-29 | 2014-04-17 | 第三军医大学第一附属医院 | Multifunctional ablation catheter system for renal sympathetic denervation |
CN102908189B (en) | 2012-08-29 | 2015-04-08 | 中国人民解放军第三军医大学第一附属医院 | Multifunctional ablation catheter system for denervation of renal sympathetic nerves |
CN102885649B (en) | 2012-08-29 | 2015-01-21 | 中国人民解放军第三军医大学第一附属医院 | Radio frequency cable controlled ablation catheter system for removing sympathetic nerve from kidney |
WO2014047224A1 (en) | 2012-09-19 | 2014-03-27 | Cardiac Pacemakers, Inc. | Fixation mechanisms for temporary implantable medical electrical stimulation leads |
US20140249524A1 (en) | 2013-03-01 | 2014-09-04 | Boston Scientific Scimed, Inc. | System and method for performing renal nerve modulation |
US20140303617A1 (en) | 2013-03-05 | 2014-10-09 | Neuro Ablation, Inc. | Intravascular nerve ablation devices & methods |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
AU2014249776B2 (en) | 2013-03-12 | 2017-04-20 | Boston Scientific Scimed, Inc. | Medical systems and methods for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
WO2014176785A1 (en) | 2013-05-03 | 2014-11-06 | 上海安通医疗科技有限公司 | Nerve regulation device |
CA2913346A1 (en) | 2013-06-05 | 2014-12-11 | Metavention, Inc. | Modulation of targeted nerve fibers |
CN105682594B (en) | 2013-07-19 | 2018-06-22 | 波士顿科学国际有限公司 | Helical bipolar electrodes renal denervation dominates air bag |
US9913684B2 (en) | 2013-08-23 | 2018-03-13 | Oscor Inc. | Steerable ablation catheter for renal denervation |
US20150126992A1 (en) | 2013-11-05 | 2015-05-07 | Mogul Enterprises, Inc | Helical DeNervation Ablation Catheter Apparatus |
JP2015119831A (en) | 2013-12-24 | 2015-07-02 | テルモ株式会社 | Ablation catheter |
WO2015120340A1 (en) | 2014-02-07 | 2015-08-13 | Verve Medical, Inc. | Methods and systems for ablation of the renal pelvis |
US20150223877A1 (en) | 2014-02-12 | 2015-08-13 | Perseus-Biomed Inc. | Methods and systems for treating nerve structures |
CN105012009B (en) | 2014-04-22 | 2018-09-28 | 上海微创电生理医疗科技有限公司 | A kind of renal artery radiofrequency ablation electrode catheter |
WO2015164280A1 (en) * | 2014-04-24 | 2015-10-29 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having braided shafts and associated systems and methods |
CN106456239A (en) | 2014-05-28 | 2017-02-22 | 波士顿科学国际有限公司 | Nerve modulation devices with cooling capabilities |
CN105167840A (en) | 2014-06-20 | 2015-12-23 | 上海安通医疗科技有限公司 | Multi-electrode renal artery radiofrequency ablation catheter |
CN105326562A (en) | 2014-06-24 | 2016-02-17 | 上海安通医疗科技有限公司 | Catheter device for regulating renal nerves |
JP2016086999A (en) | 2014-10-31 | 2016-05-23 | テルモ株式会社 | Ablation catheter |
AU2015367281A1 (en) | 2014-12-17 | 2017-06-29 | Cathrx Ltd | An improved catheter and method of manufacture thereof |
US9795780B2 (en) | 2014-12-18 | 2017-10-24 | Abbott Cardiovascular Systems Inc. | System for denervation |
US9737361B2 (en) | 2014-12-18 | 2017-08-22 | Abbott Cardiovascular Systems Inc. | System and method for a catheter |
CN205433878U (en) | 2015-12-08 | 2016-08-10 | 上海安通医疗科技有限公司 | Radiofrequency ablation catheter for renal arteries |
CN205433879U (en) | 2015-12-08 | 2016-08-10 | 上海安通医疗科技有限公司 | Radiofrequency ablation catheter for renal arteries |
AT521173B1 (en) | 2018-06-27 | 2019-11-15 | Trumpf Maschinen Austria Gmbh & Co Kg | Bending tool with spacer element |
-
2013
- 2013-09-09 US US14/021,838 patent/US20150073515A1/en not_active Abandoned
-
2014
- 2014-09-09 EP EP14772511.3A patent/EP3043857B1/en active Active
- 2014-09-09 CN CN201480049431.5A patent/CN105555348B/en active Active
- 2014-09-09 WO PCT/US2014/054654 patent/WO2015035350A1/en active Application Filing
-
2019
- 2019-03-01 US US16/290,565 patent/US11213678B2/en active Active
-
2021
- 2021-12-09 US US17/546,600 patent/US20220096826A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322559B1 (en) * | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US20050267465A1 (en) * | 2004-05-26 | 2005-12-01 | Baylis Medical Company Inc. | Multifunctional electrosurgical apparatus |
US20130304062A1 (en) * | 2012-05-14 | 2013-11-14 | Biosense Webster (Irael), Ltd. | Catheter with helical end section for vessel ablation |
US20140276747A1 (en) * | 2013-03-15 | 2014-09-18 | Abbott Cardiovascular Systems Inc. | System and method for denervation |
US20140276748A1 (en) * | 2013-03-15 | 2014-09-18 | Medtronic Ardian Luxembourg S.a.r.I. | Helical Push Wire Electrode |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE48460E1 (en) | 2002-09-30 | 2021-03-09 | Relievant Medsystems, Inc. | Method of treating an intraosseous nerve |
US10478246B2 (en) | 2002-09-30 | 2019-11-19 | Relievant Medsystems, Inc. | Ablation of tissue within vertebral body involving internal cooling |
US10111704B2 (en) | 2002-09-30 | 2018-10-30 | Relievant Medsystems, Inc. | Intraosseous nerve treatment |
US11596468B2 (en) | 2002-09-30 | 2023-03-07 | Relievant Medsystems, Inc. | Intraosseous nerve treatment |
US10463423B2 (en) | 2003-03-28 | 2019-11-05 | Relievant Medsystems, Inc. | Thermal denervation devices and methods |
US10905440B2 (en) | 2008-09-26 | 2021-02-02 | Relievant Medsystems, Inc. | Nerve modulation systems |
US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
US10265099B2 (en) | 2008-09-26 | 2019-04-23 | Relievant Medsystems, Inc. | Systems for accessing nerves within bone |
US11471171B2 (en) | 2008-09-26 | 2022-10-18 | Relievant Medsystems, Inc. | Bipolar radiofrequency ablation systems for treatment within bone |
US10390877B2 (en) | 2011-12-30 | 2019-08-27 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
US11471210B2 (en) | 2011-12-30 | 2022-10-18 | Relievant Medsystems, Inc. | Methods of denervating vertebral body using external energy source |
US11690667B2 (en) | 2012-09-12 | 2023-07-04 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
US11701168B2 (en) | 2012-09-12 | 2023-07-18 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
US11737814B2 (en) | 2012-09-12 | 2023-08-29 | Relievant Medsystems, Inc. | Cryotherapy treatment for back pain |
US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
US11291502B2 (en) | 2012-11-05 | 2022-04-05 | Relievant Medsystems, Inc. | Methods of navigation and treatment within a vertebral body |
US9775627B2 (en) | 2012-11-05 | 2017-10-03 | Relievant Medsystems, Inc. | Systems and methods for creating curved paths through bone and modulating nerves within the bone |
US10357258B2 (en) | 2012-11-05 | 2019-07-23 | Relievant Medsystems, Inc. | Systems and methods for creating curved paths through bone |
US11160563B2 (en) | 2012-11-05 | 2021-11-02 | Relievant Medsystems, Inc. | Systems for navigation and treatment within a vertebral body |
US10517611B2 (en) | 2012-11-05 | 2019-12-31 | Relievant Medsystems, Inc. | Systems for navigation and treatment within a vertebral body |
US11234764B1 (en) | 2012-11-05 | 2022-02-01 | Relievant Medsystems, Inc. | Systems for navigation and treatment within a vertebral body |
US11065046B2 (en) | 2013-08-08 | 2021-07-20 | Relievant Medsystems, Inc. | Modulating nerves within bone |
US10456187B2 (en) | 2013-08-08 | 2019-10-29 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
EP3222237A1 (en) * | 2016-03-24 | 2017-09-27 | Cook Medical Technologies LLC | Medical device |
US20170273736A1 (en) * | 2016-03-24 | 2017-09-28 | Cook Medical Technologies Llc | Medical device |
US11454627B2 (en) * | 2017-01-26 | 2022-09-27 | Katholieke Universiteit Leuven | Sensor |
CN109907822A (en) * | 2019-04-09 | 2019-06-21 | 北京博海康源医疗器械有限公司 | A kind of RF ablation closure microtubular |
US20220218412A1 (en) * | 2019-05-07 | 2022-07-14 | CRC EP, Inc. | Mapping and ablation catheter with multiple loop segments |
US11426199B2 (en) | 2019-09-12 | 2022-08-30 | Relievant Medsystems, Inc. | Methods of treating a vertebral body |
US11207100B2 (en) | 2019-09-12 | 2021-12-28 | Relievant Medsystems, Inc. | Methods of detecting and treating back pain |
US11202655B2 (en) | 2019-09-12 | 2021-12-21 | Relievant Medsystems, Inc. | Accessing and treating tissue within a vertebral body |
US11123103B2 (en) | 2019-09-12 | 2021-09-21 | Relievant Medsystems, Inc. | Introducer systems for bone access |
US11007010B2 (en) | 2019-09-12 | 2021-05-18 | Relevant Medsysterns, Inc. | Curved bone access systems |
CN113693716A (en) * | 2020-05-22 | 2021-11-26 | Tau-Pnu医疗有限公司 | Radiofrequency electrode ablation catheter with cooling function for interventricular therapy |
US20220061915A1 (en) * | 2020-05-22 | 2022-03-03 | Tau-Pnu Medical Co., Ltd. | Rf ablation catheter for septal reduction therapy having cooling effect |
CN113693717A (en) * | 2021-08-30 | 2021-11-26 | 上海安通医疗科技有限公司 | Radio frequency ablation catheter for radial artery access |
CN116059533A (en) * | 2023-02-20 | 2023-05-05 | 湖南安泰康成生物科技有限公司 | Active heat dissipation electrode slice and electrode device |
Also Published As
Publication number | Publication date |
---|---|
EP3043857B1 (en) | 2017-11-08 |
EP3043857A1 (en) | 2016-07-20 |
US20190192849A1 (en) | 2019-06-27 |
US20220096826A1 (en) | 2022-03-31 |
WO2015035350A1 (en) | 2015-03-12 |
CN105555348B (en) | 2019-03-01 |
CN105555348A (en) | 2016-05-04 |
US11213678B2 (en) | 2022-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11213678B2 (en) | Method of manufacturing a medical device for neuromodulation | |
US10512504B2 (en) | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods | |
US20180177548A1 (en) | Helical push wire electrode | |
US20150359589A1 (en) | Intravascular neuromodulation device having a helical therapeutic assembly with proud portions and associated methods | |
US11950826B2 (en) | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods | |
US20150230859A1 (en) | Bi-directional deployment of neuromodulation devices and associated systems and methods | |
WO2015047817A1 (en) | Intravascular neuromodulation device having a spiral track and associated methods | |
US20150066118A1 (en) | Intravascular Neuromodulation Device Having a Spiral Track and Associated Methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L., LUXEMBOURG Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TUROVSKIY, ROMAN;LARIOS, MARIA VERONICA;REEL/FRAME:031705/0872 Effective date: 20131017 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |